Systems and methods for visualizing patient and telepresence device statistics in a healthcare network

Information

  • Patent Grant
  • 10762170
  • Patent Number
    10,762,170
  • Date Filed
    Monday, November 23, 2015
    9 years ago
  • Date Issued
    Tuesday, September 1, 2020
    4 years ago
Abstract
Disclosed herein are various embodiments of systems and methods for visualizing, analyzing, and managing telepresence devices operating in a telepresence network of healthcare facilities. A user may selectively view a global view of all telepresence devices, telepresence devices within a particular region, the details of a particular telepresence device, and/or the details of a particular healthcare facility. At one viewing level, a user may view a plan view map of a healthcare facility and visualize the navigational history of a telepresence device. At another viewing level, a user may view a plan view map of a healthcare facility and visualize telemetry data of a patient associated with a selected room. At another viewing level, a user may selectively view various graphical representations of telepresence device statistics and usage information with respect to health ratings for each of a plurality of patients.
Description
TECHNICAL FIELD

This disclosure relates to managing telepresence devices in healthcare networks. More specifically, this disclosure provides various visualization and management systems for use with telepresence devices, healthcare networks, and associated information.





BRIEF DESCRIPTION OF THE DRAWINGS

Non-limiting and non-exhaustive embodiments of the disclosure are described herein, including various embodiments of the disclosure illustrated in the figures listed below.



FIG. 1 illustrates a viewing level including a geographical representation of the world, shortcut links to various geographical locations, selectable icons associated with various device types, a navigation input panel, and selectable overlays.



FIG. 2 illustrates a viewing level of a geographical representation of the United States with a population density overlay.



FIG. 3 illustrates a shortcut menu configured to allow for direct navigation to various locations within a geographical representation.



FIGS. 4A and 4B illustrate context-based detail request menus providing access to specific details based on the type of telepresence device and/or type of healthcare facility.



FIG. 5 illustrates a viewing level including a session viewer for monitoring sessions and telepresence devices during a selected time period.



FIG. 6 illustrates a detailed session viewer for monitoring a location of a telepresence device at various time periods on a geographical representation, the geographical representation including an overlay of wireless communication availability.



FIGS. 7A and 7B illustrate viewing levels including the location and interconnections of medical facilities in a healthcare network on a geographical representation.



FIG. 8 illustrates a viewing level providing stroke information associated with a healthcare network on a geographical representation.



FIG. 9 illustrates a viewing level including a dashboard of detailed information associated with one or more telepresence devices.



FIG. 10 illustrates a viewing level including session details for a particular telepresence device.



FIG. 11 illustrates a viewing level including stroke information associated with a healthcare network provided via a StrokeRESPOND application.



FIG. 12 illustrates a viewing level showing navigational paths of a telepresence device on a plan map for a selected time period.



FIG. 13 illustrates a viewing level showing telemetry data for a patient as a pop-up window on a plan map in a selected room of a healthcare facility.



FIG. 14 illustrates a table of patients, outcome ratings, and telepresence device statistics associated with each of the patients.



FIG. 15 illustrates a coordinate system including selected graphs of patient outcome ratings and various telepresence device statistics.



FIG. 16 illustrates a coordinate system including graphs of patient outcome ratings, a number of visits per day, and a number of stethoscope uses.



FIG. 17 illustrates a coordinate system including graphs of patient outcome ratings, a number of visits per day, and a number of stethoscope uses, where the patients included on the coordinate system are filtered based on a specific health condition.



FIG. 18A illustrates a graph of patient outcome ratings and an amount of time a camera of a telepresence device is zoomed greater than 50%.



FIG. 18B illustrates a graph of patient outcome ratings and an amount of time a camera of a telepresence device is zoomed greater than 50%, where the patients included on the coordinate system are filtered to include only those with a neurological condition.



FIG. 19 illustrates a graph of patient outcome ratings and selected telepresence device statistics, including a selection of patients filtered by physician contrasted with similar telepresence device statistics for all of the patients (unfiltered).



FIG. 20 illustrates a graph of patient outcome ratings and selected telepresence device statistics, including a selection of patients filtered by room number contrasted with similar telepresence device statistics for all of the patients (unfiltered).



FIG. 21 illustrates a functional block diagram of a computer system including various modules for a telepresence network visualization and management system.





The described features, structures, and/or characteristics of the systems and methods described herein may be combined in any suitable manner in one or more alternative embodiments, and may differ from the illustrated embodiments.


DETAILED DESCRIPTION

The present disclosure provides various systems and methods for visualizing and managing telepresence devices within healthcare networks and facilities. Using the presently described visualization and management tool, users may more efficiently visualize, analyze, and actively manage various aspects of a telepresence healthcare network. In some embodiments, a user may view a geographical representation of the relative location of each of a plurality of telepresence devices in a telepresence network.


Healthcare facilities may include telemedicine technologies, such as telepresence devices in a telepresence network, that allow remote healthcare practitioners to provide services to patients and/or other healthcare practitioners in remote locations. For example, a remote medical professional may be a neurologist practicing in a major hospital who may, via telepresence devices, provide services and consultations to patients and other medical professionals in hospitals located in rural areas that may otherwise not have a neurologist on staff.


The telepresence devices may operate as part of a telepresence network associated with one or more healthcare networks. Each healthcare network may include one or more healthcare facilities (e.g., hospitals, rehabilitation facilities, and long-term care facilities) that each have one or more telepresence devices. Types of telepresence devices include, but are not limited to, remote telepresence devices, mobile telepresence units, and/or control stations. For example, a remote telepresence device may include a telepresence robot configured to move within a medical facility and provide a means for a remote practitioner to perform remote consultations.


A visualization and management system for telepresence devices may be configured to display a first viewing level that includes a geographical representation of the location of various telepresence devices. The viewing level may include all telepresence devices, those within predefined geographical boundaries, those associated with a particular healthcare network, or those associated with a particular healthcare facility. The telepresence devices and/or healthcare facilities may also be displayed as hub devices/facilities and spoke devices/facilities. The various interconnections between the hubs and spokes may be selectively displayed.


A navigation control panel may allow a user to navigate within the geographical representation. For example, the navigation panel may allow for panning, tilting, scrolling, compass alignments, and/or other navigational options. Additionally, the field of view may be dynamically modified based on a user's selection. For example, the field of view may be controlled by a zooming panel or icon, or alternatively may be dynamically adjusted based on other navigational or icon selections. The information associated with the displayed telepresence devices and/or healthcare facilities may be limited or expanded based on the number of telepresence devices and/or healthcare facilities currently displayed in the selected field of view. In some embodiments, shortcuts may allow a user to quickly navigate to a specific geographical location, to a specific medical facility, to a specific medical network, and/or to a specific telepresence device.


The first viewing level may include various icons, panels, buttons, and/or other selectable options configured to allow a user to select one or more alternative viewing levels. For example, a device detail request module may allow a user to submit a detail request in order to view detailed information associated with one or more telepresence devices, healthcare facilities, and/or healthcare practitioners shown on the geographical representation. A user may request additional details by selecting a particular telepresence device and/or healthcare facility. In some embodiments, additional details may be presented when a user mouses over a device/facility. The mouse-over may cause a pop-up overlay to appear displaying additional details associated with the device/facility. The details associated with one or more telepresence devices may include the connection strength, the number of active sessions, a history of technical problems, a history of session activity, shipping information associated with a telepresence device, information associated with a software update, information associated with a firmware update, a serial number, a model number, a battery level, a date the telepresence device last reported, a time the telepresence device last reported, historical session data, a registered peripheral, a licensed application, a total utilization time, an average session duration, a duration of a particular session, a start time of a particular session, an end time of a particular session, a Quality of Service (QoS) for one or more sessions, a current available bandwidth, a bandwidth availability with respect to time, a current location of a telepresence device, and historical locations of a telepresence device with respect to time.


Similarly, the details associated with one or more healthcare facilities may include a number of active sessions, a number of active telepresence devices, a connection strength of telepresence devices, a connection between two or more telepresence devices, a location of a telepresence device, information from a StrokeRESPOND application, a door-to-needle time, a door-to-balloon time, t-PA contraindication and warning information, a healthcare practitioner response time, and a call center response time.


Additionally, details associated with a particular telepresence device, healthcare facility, healthcare network, and/or healthcare practitioner may include one or more connection rules. For example, connection rules may define where, when, and how a healthcare facility, healthcare network, and/or healthcare practitioner may access, view, monitor, and/or control a particular telepresence device or set of telepresence devices. The connection rules may also define who is granted access and what devices they can view. In some embodiments, a viewing level displaying one or more connection rules may allow a user to manage and/or configure the various connection rules between devices, facilities, and/or practitioners. In one embodiment, connection rules may be managed using drag-and-drop actions between devices, facilities, and/or practitioners.


Some of the viewing levels may include geographical representations constrained by particular geographical boundaries, the extent of a healthcare network, or the location of associated telepresence devices. Some of the viewing levels may include selectable overlays configured to overlay information on the geographical representations. Accordingly, a user may apply an informational overlay to a geographical representation that includes various healthcare facilities and/or telepresence devices.


Examples of overlays include, but are not limited to, a population density, a stroke frequency, an adoption rate of a software update, an adoption rate of a firmware update, a frequency of a particular medical condition, a frequency of a particular technical difficulty, an average age of the population, an average age of patients, socioeconomic conditions, an availability of wireless communications, a relative location of medical practitioners, active sessions, a data connection strength, and a relative location of support technicians. The informational overlay may be overlaid on the geographical representation as a heat map, as graphics, as pictures, as icons, as numbers, and/or as text.


In some embodiments, the informational overlay may be overlaid on the entire geographical representation. In other embodiments, the informational overlay may be overlaid on a portion of the geographical representation. For example, the informational overlay may only be overlaid on the portion of a geographical representation that corresponds to a geographical area serviced by a particular healthcare network, hospital, hub hospital, spoke hospital, telepresence device, support technician, and/or medical practitioner.


In some embodiments, a viewing level may include a geographical representation displaying the relative location of various telepresence devices. The viewing level may include various selectable device icons that each correspond to a particular type of telepresence device. The device icons may be used to toggle between displaying and not displaying the associated type of telepresence device. Accordingly, a user may toggle the device icons in order to view all of the control stations, but not the mobile telepresence units or the remote telepresence robots. Within the same viewing level, the user may toggle the device icons to view the remote telepresence robots and/or the mobile telepresence units, but not the control stations. Additional device icons may further differentiate between device types, models, vintages, active telepresence devices, inactive telepresence devices, and/or other characteristics of the various telepresence devices.


The visualization and management of telepresence networks may allow healthcare facilities, healthcare networks, healthcare practitioners, technical support personnel, and/or other users to improve patient care, provide enhanced telepresence services, reduce the costs associated with telepresence consultations, and/or otherwise improve existing technologies and systems. Suitable networks for use with the present visualization and management systems include any of a wide variety of physical infrastructures, protocols, connections, and encryption algorithms. According to various embodiments, networking practices may be implemented in order to comply with accepted healthcare standards and/or government regulations.


Some viewing levels may include plan map views allowing a user to visualize navigational paths of a telepresence device on one or more floors of a healthcare facility. In some embodiments, a user may visualize and distinguish between navigational paths in which a telepresence device was in an automated mode and navigational paths in which the telepresence device was in a teleoperated mode. Additionally, in one viewing level a user may select (e.g., via a click or a mouse-over) a room and view telemetry data associated with a patient in the selected room for a given time period.


Additionally, various viewing levels may allow a user to selectively visualize and filter data associated with patients, healthcare practitioners (e.g., a primary physician), and telepresence device statistics related to the usage of a telepresence device with respect to a particular patient or by a particular healthcare practitioner. In various examples, a coordinate system may be selectively populated with various graphs of telepresence device statistics, as described herein. The graphs may be filtered based on various criteria as selected by the user. The visualization may allow a user to easily and quickly find correlations between the manner in which a telepresence device is used and the outcome of a patient.


Various aspects of this disclosure are also described in U.S. patent application Ser. No. 13/444,106, filed Apr. 11, 2012 titled “SYSTEMS AND METHODS FOR VISUALIZING AND MANAGING TELEPRESENCE DEVICES IN HEALTHCARE NETWORKS,” which application is incorporated herein by reference in its entirety.


The term “coordinate system” may refer to any type of organized visual or graphical representation of data. For example, a coordinate system may comprise, utilize, and/or incorporate a bar graph, a line chart, a plot, a diagram, a pie chart, a number line, a Cartesian coordinate system, a histogram, a cylindrical and/or spherical coordinate system, a timeline, a cartogram, a pedigree chart, a bubble chart, a polar area diagram, a waterfall chart, a tree, a polar coordinate system, a mapping, a radar chart, a distribution system, a scattergram, a Gantt chart, a Smith chart, a Nolan chart, a scatterplot, a color-coordinated data set, and/or other visual representation of data. The term “graph” as used herein may refer to any type of data representation within a coordinate system. For example, a graph may be a line drawn on a Cartesian coordinate system, a slice of a pie chart, a point on a scattergram, and/or other data representation on a coordinate system as defined herein.


Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, the appearances of the phrases “in one embodiment” and “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. In particular, an “embodiment” may be a system, an article of manufacture (such as a computer-readable storage medium), a method, and/or a product of a process.


The phrases “connected to” and “in communication with” refer to any form of interaction between two or more entities, including mechanical, electrical, magnetic, and electromagnetic interaction. Two components may be connected to each other even though they are not in direct contact with each other and even though there may be intermediary devices between the two components.


The embodiments of the disclosure will be best understood by reference to the drawings, wherein like elements are designated by like numerals throughout. In the following description, numerous specific details are provided for a thorough understanding of the embodiments described herein. However, those of skill in the art will recognize that one or more of the specific details may be omitted, or other methods, components, or materials may be used. In some cases, operations are not shown or described in detail.


Furthermore, the described features, operations, or characteristics may be combined in any suitable manner in one or more embodiments. The order of the steps or actions of the methods described in connection with the embodiments disclosed may be varied. Thus, any order in the drawings or Detailed Description is for illustrative purposes only and is not meant to imply a required order, unless otherwise specified.


Embodiments may include various features, which may be embodied in machine-executable instructions executed by a general-purpose or special-purpose computer (or other electronic device). Alternatively, the features may be performed by hardware components that include specific logic for performing the steps or by a combination of hardware, software, and/or firmware. Accordingly, the various components, modules, systems, and/or features described herein may be embodied as modules within a system. Such a system may be implemented in software, firmware, hardware, and/or physical infrastructure.


Embodiments may also be provided as a computer program product including a non-transitory machine-readable medium having stored thereon instructions that may be used to program or be executed on a computer (or other electronic device) to perform processes described herein. The machine-readable medium may include, but is not limited to, hard drives, floppy diskettes, optical disks, CD-ROMs, DVD-ROMs, ROMs, RAMs, EPROMs, EEPROMs, magnetic or optical cards, solid-state memory devices, or other types of media/machine-readable media suitable for storing electronic instructions.



FIG. 1 illustrates a global viewing level 100 of a geographical representation of the world 110. As illustrated, the global viewing level 100 may include a navigation panel 120 with various icons configured to allow a user to pan, rotate, tilt, and zoom within the global viewing level. For instance, a slider bar may be slid between a “−” sign and a “+” sign in order to control the field of view of the geographical representation 110. A wide field of view may include the entire globe, as illustrated, and a narrow field of view may be limited to a single telepresence device and/or healthcare facility. The global viewing level 100 may include various quick links 130. A user may use the quick links 130 to navigate to a specific location on the geographical representation 110 and/or automatically adjust the field of view.


The viewing level 100 may also include a panel 140 of device-type icons. By selecting a device icon in the panel 140, a user may choose whether or not the particular device type is displayed on the geographical representation 110. For example, the illustrated viewing level 100 displays icons representing various telepresence devices on the geographical representation 110. By toggling the device-type icons within the panel 140, a user may selectively view one or more types of telepresence devices and disable the display of the other types. Accordingly, a user may filter by telepresence device type.


Additionally, the viewing level 100 may include selectable overlays within an overlay panel 150. The selectable overlays may include, but are not limited to, a population density, a stroke frequency, an adoption rate of a software update, an adoption rate of a firmware update, a frequency of a particular medical condition, a frequency of a particular technical difficulty, an average age of the population, an average age of patients, socioeconomic conditions, an availability of wireless communications, a relative location of medical practitioners, active sessions, a data connection strength, and a relative location of support technicians. The informational overlay may be overlaid on the geographical representation 110 as a heat map, as graphics, as pictures, as icons, as numbers, and/or as text. A user may apply an overlay on the geographical representation 110 in order to visualize the relationships between the information conveyed by the overlay, technical data, healthcare networks, and/or telepresence devices.


A lower panel 160 may include additional selectable icons and/or display information about the current session. For example, a reset icon may allow a user to reset or refresh the visualization and management system. A customer networks icon may allow the user to switch from a geographical representation of the relative location of telepresence devices to a geographical representation of the relative location of healthcare facilities and/or healthcare networks, or to a connectivity control panel.


For purposes of this disclosure, the selection of an icon within any of the panels 130, 140, 150, and 160 may be considered a transition from the viewing level 100 to a different viewing level. Alternatively, the selection of some of the icons within the panels 130, 140, 150, and/or 160 may display additional information, remove displayed information, and/or modify displayed information but remain within the same viewing level. The viewing level 100 illustrated in FIG. 1 may be displayed in a web browser, potentially using one or more plug-ins. Alternatively, the various viewing levels may be displayed and/or controlled in a stand-alone application or in any other suitable computing environment.



FIG. 2 illustrates a viewing level 200 with a narrower field of view showing a heat map overlaid on a geographical representation 210. The illustrated geographical representation 210 includes the continental United States. As illustrated, an overlay panel 220 may include various informational overlays that may be applied to the geographical representation 210. The overlays may be applied in any of a wide variety of manners, such as by applying a corresponding heat map, graphics, pictures, icons, numbers, and/or text. In the illustrated embodiment, the white dots on the geographical representation 210 may represent available telepresence devices.


The heat map overlay may correspond to a population density. Accordingly, it may be useful (e.g., to assess need or sales opportunities) to compare the population density across the continental United States to the location of available/existing telepresence devices. For instance, in the illustrated example, the population density near the border of Illinois and Iowa is relative high, and yet there is no telepresence device nearby. Accordingly, a sales opportunity or need may exist in that region.



FIG. 3 illustrates a “Quick Nav” shortcut menu 310 configured to allow for direct navigation to a location within the geographical representation 320. The Quick Nav menu 310 may be customized and/or include various default locations. Any number of selectable locations may be included in the shortcut menu 310. Selecting a location within the shortcut menu 310 may pan, rotate, tilt, and/or zoom the window in order to frame the selected geographical location. The telepresence devices and/or healthcare facilities within the framed geographical representation 320 may be displayed as icons resembling corresponding types of telepresence devices and/or healthcare facilities. Alternatively, other symbols, icons, coloring, numbers, text, or markings may be utilized to display the relative location of various telepresence devices and/or healthcare facilities within the displayed geographical boundaries. In the illustrated embodiment, robotically controlled telepresence devices are illustrated with robot icon 322, and mobile telepresence units are illustrated with an icon 325 resembling the device type.



FIGS. 4A and 4B illustrate context-based detail request menus 400 and 450 providing access to specific details based on the type of telepresence device and/or type of healthcare facility. The detailed information, titles, names, and icons used in the menus 400 and 450 may be modified or adapted for a particular application or need. As illustrated in FIG. 4A, by right-clicking (or through the use of another secondary selection method) on the robot icon, a user may select various viewing details or management details in the panel 410. Detail requests may include information associated with telepresence devices, communication sessions, shipment history, and available networks. Additionally, a user may select various management details, such as connectivity and support. Different types of telepresence devices may include different detail selection options for viewing and/or managing. Moreover, the identity of the user may modify which selectable detail requests are available. For example, an administrator of a telepresence device may have more access than a low-level healthcare practitioner.


As illustrated in FIG. 4B, when a healthcare facility icon is right-clicked, a different detail request panel 460 may be displayed. The selectable detail requests within the panel 460 may be based on the identity of the user, a characteristic of the user, the type of healthcare facility, and/or the types of available telepresence devices associated with the healthcare facility. As illustrated, a user may select to view additional details associated with endpoints (telepresence devices) associated with the healthcare facility, connection rules, utilization statistics of telepresence devices, transfer statistics, and other interfacing applications. Additionally, the user may select to manage details such as connectivity, support, and/or a dashboard of other informational details.


Hovering a mouse over a telepresence device icon and/or a healthcare facility icon (a mouse-over) may display one or more details about the specific device/facility. For example, a mouse-over may display the serial number of a telepresence device and the hospital with which it is associated. Additional information may be displayed via a mouse-over and/or by selecting the icon representing the device/facility.


Any of the selectable icons, panels, and/or options may be accessible in any of the viewing levels described herein. Specifically, the viewing level requests via navigation panels and/or shortcut menus (illustrated in FIGS. 1 and 3), the available overlays (illustrated in FIG. 2), and the detail request panels (illustrated in FIGS. 4A and 4B) may be available in the viewing level illustrated in FIG. 1. The exact depictions of icons, panels, geographical representations, and other specific details illustrated and/or described in conjunction with the figures are merely exemplary and may be modified, augmented, replaced, and/or eliminated for a particular application.



FIG. 5 illustrates a viewing level 500 including a session viewer for visualizing and/or managing sessions and telepresence devices during a selected time period. The session viewer in viewing level 500 may allow a user to visualize data relating to specific remote telepresence sessions on a geographical representation 510. The visualization may include a set of lines or arcs representing the connections. As illustrated, a time period may be selected in the panel 520, the total number of active sessions may be illustrated in the active sessions panel 530, and the active telepresence devices (endpoints) may be illustrated in the panel 540. Icons representing various telepresence devices, healthcare facilities, and/or communication connections may be displayed on the geographical representation 510, as illustrated in FIG. 5.


In various embodiments, visual attributes and/or text associated with the communication connections may be indicative of a telepresence session's quality, control station used, servers used, and/or other session data. For example, the visual appearance of a communication connection may be modified based on the session's quality, the control station, which server was used to negotiate the connection, the endpoint, the type of session (peer-to-peer or server-based), and/or other session data. A single session, a set of sessions from multiple endpoint and control station pairs at a single point in time, and/or a set of multiple sessions over a time span specified by the user may also be provided in this or another viewing level.


In various embodiments, a viewing level including a session viewer as illustrated in FIG. 5 may allow a user to view the number of active sessions, a list of active telepresence devices, and filtering options to limit the types of devices displayed, the connection types, the server types, the time period, and/or other attributes of telepresence sessions. In some cases, a user may view session data associated with a particular mobile telepresence unit. The visualization and management system may display a geographical representation bounded by a travel area of the mobile telepresence unit.


As illustrated in FIG. 6, various overlays may be used in conjunction with the session viewer viewing level in order to provide additional information about a particular telepresence session. A viewing level 600 may include a route 620 traveled by a mobile telepresence device 625 over a given time period. The viewing level 600 may also include robot telepresence devices 630 and 635 with which the mobile telepresence device 625 communicated. The relative location of the mobile telepresence device 625 may move along the route 620 as the time is moved along the timeline 650 from 4:32 to 5:58 (corresponding to the beginning and end of one or more telepresence sessions).


An overlay, such as 3G and 4G cellular data availability, may be selected from the panel 610 and overlaid on the geographical representation of the viewing level 600 in order to provide additional information to the user. The user may diagnose communication problems and/or improve the overall telepresence session experience using various informational overlays. Such a viewing level may be particularly useful for visualizing and/or managing the use of mobile telepresence units transported in ambulances and/or used remotely by healthcare practitioners (e.g., while at home or on vacation). For example, while monitoring a number of active sessions in a session viewer as illustrated in FIG. 5, a user may see an indication of a connection problem associated with a mobile telepresence device. In response, the user may open a session viewer associated with the mobile telepresence device, as illustrated in FIG. 6, and choose to overlay 3G and/or 4G cellular data availability to investigate and discover possible causes of the connection problem.


As described in conjunction with FIG. 1, a user may select a viewing level that displays the relative location of at least one healthcare facility and its relationships to other healthcare facilities on a geographical representation. FIG. 7A illustrates a hub healthcare facility, such as a hub hospital, and its relationships with other healthcare facilities as arcs extending from the hub healthcare facility to other related healthcare facilities on a geographical representation. Transitioning to the viewing level 700 may initially remove all telepresence device icons and display a new set of icons representing each customer organization. Different icons may be used to represent each type of healthcare facility and/or the capabilities of each healthcare facility. Additionally, different icons may be used to represent various classes of customers, such as hospitals, clinics, corporate headquarters, partner hospitals, and others. Similar to the description above, hovering over a customer icon may display the organization's name and/or some additional information. Clicking on a customer icon may display all the telepresence devices and/or hospitals associated with the customer's network. Animated arcs representing the current connectivity paths may extend from the customer hub or headquarters to the locations of current telepresence devices.


Additional details about arc connections and/or the hub hospital may be made available to a user by selecting or mousing over the icons. FIG. 7B illustrates a viewing level 750 including the location and interconnections of various healthcare facilities in a healthcare network on a geographical representation. Again, context-sensitive detail requests may be made by mousing over the healthcare facilities and/or the connections therebetween.


Additional viewing levels may include menus, icons, and/or other information for visualizing and/or managing the connectivity between various telepresence devices, healthcare practitioners, healthcare facilities, and/or healthcare networks. Additionally, details regarding how and when patients are transferred between various healthcare facilities may be presented as numerical values, as statistics, as graphs, and/or geographically on a geographical representation. In some embodiments, specific viewing levels may be available that display details associated with the shipment history of particular devices and/or software/firmware updates associated with one or more telepresence devices.


For example, a viewing level may include the shipment history of a telepresence device with respect to a timeline. The location of the telepresence device may be visualized at each point during the shipment process. Such a viewing level may allow for the optimization of transportation and shipping of telepresence devices. A viewing level may also be configured to illustrate the progress of an automatic software update from release time to some threshold of acceptance among the telepresence devices in a particular geographical area. For example, a software update is generally released to the entire fleet at a certain time and date. A telepresence device may be automatically updated when it connects to the network. The threshold of acceptance may be when 95% of all telepresence devices have reported that the new update has been installed. The viewing level may provide for the visualization of a software update on a geographical representation. For example, all telepresence devices may initially start with a red circle in their icon to show they have not accepted the update. As the user advances a time bar forward from the release date, the telepresence device icons may change color to show the status of a software update process. This might be from red (not installed) to yellow (downloading from a server) to green (installed). Accordingly, a user may gauge the effectiveness of an automatic software update system. This visualization tool may allow a user to easily identify areas, or specific telepresence devices, where the update process failed or encountered problems.


As illustrated in FIG. 8, a viewing level 800 may display information associated with a healthcare network 850 on a geographical representation 860. A timeline filter may be provided in a panel 820. Viewing level 800 may include an information selection panel 805. The viewing level 800 allows information from panel 805 that is associated with multiple healthcare facilities and/or telepresence devices shown in a key 810 to be visually presented in conjunction with a geographical representation 860. A user may select between a variety of informational overlays, graphs, informational tags, icons, text, numbers, connection lines, and/or colors to visually convey information related to healthcare facilities and/or telepresence devices. According to various embodiments, a user may graphically compare data among spoke healthcare facilities or between spoke healthcare facilities and a hub healthcare facility (see the key 810) on the geographical representation 860.


In the illustrated embodiment, stroke information has been selected in the information selection panel 805. Accordingly, a user may view the number of patients who were the subject of a stroke consultation made by a healthcare practitioner in a hub healthcare facility using telepresence devices. A user may view the number of such patients who were determined fit to stay in the rural (spoke) healthcare facilities, and those who were transferred to the more capable hub healthcare facility. Such a viewing level may allow for a visualization of the effectiveness and results of consultations via telepresence devices.


The viewing level 800 may allow a user to visualize the value a telepresence system is bringing to a customer's hub hospital and spoke hospitals in terms of patients kept and acute cases transferred. For example, a rural hospital's administrator may visualize the number of patients who were subject to a telepresence consultation performed by a specialist based in a hub hospital. The rural healthcare facility may have a small graph beside it indicating the number of patients kept versus the total number of stroke patients admitted in the selected time period. The healthcare facility may also have an arrow configured with a width corresponding to the relative number of patients transferred from the spoke healthcare facility to the hub healthcare facility. Accordingly, the rural hospital administrator (and the hub hospital administrator) may visualize the benefits of the telepresence devices and telepresence network.


The user may select a different information set from the information selection panel 805 in order to visualize data relating to a particular facility or device, or visually compare data between and/or among various spoke and hub healthcare facilities on the geographical representation 860. Additionally, information directly related to the telepresence devices may be selected within information selection panel 805, in order for a user to visually compare the status of telepresence devices between spoke healthcare facilities on the geographical representation 860. Information sets selectable via the information selection panel 805 may include, but are not limited to, information related to medical condition, such as stroke or heart attack, utilization rates, session quality information, telepresence device information, support activity, battery levels, last reported time, active session, workflow metrics, available telepresence devices, trained specialists, financial information, subscription information, and/or other information associated with telepresence devices, telepresence networks, healthcare facilities, and/or healthcare networks.



FIG. 9 illustrates a viewing level 900 including a dashboard of detailed information 920, 930, 940, 950, and 960 associated with one or more telepresence devices. The displayed details may include various numerical information, charts, and/or graphs. The information displayed in the dashboard of information may depend on the types of telepresence devices, the types of healthcare facilities, and/or the identity of the user. A navigation bar 910 may allow the user to navigate between various viewing levels. In the illustrated example, an endpoints panel 920 may include details associated with one or more endpoints (telepresence devices) in a healthcare facility. The endpoints panel 920 may include real-time information associated with a particular telepresence device, including, but not limited to, serial number, model number, type, name, battery level, connection status, location, date and time last reported, available peripherals, and associated applications.


A utilization panel 930 may display details associated with the remote telepresence sessions for one or more telepresence devices and/or a particular healthcare facility or network. For example, the utilization panel 930 may include details regarding utilization over various time periods, a total utilization time, an average session duration, a duration of a particular session, a start time and end time of a particular session, a Quality of Service (QoS) for one or more sessions, a current available bandwidth, a bandwidth availability with respect to time, a current location of a telepresence device, and historical locations of a telepresence device with respect to time.


A support panel 950 may display information associated with technical support, software updates, firmware updates, hardware updates/replacements, and/or other support issues. The support panel 950 may display a list of personnel responsible for a telepresence device and/or healthcare facility. Historical data regarding support issues may also be available. Automatic and/or manual updates may be applied via support panel 950 as well.


An application panel 960 may provide information associated with applications registered for use with the telepresence device and/or healthcare facility. Information associated with various workflow applications, such as StrokeRESPOND described in U.S. patent application Ser. No. 12/362,454, filed on Jan. 29, 2009, titled “DOCUMENTATION THROUGH A REMOTE PRESENCE ROBOT,” which application is hereby incorporated by reference in its entirety, may also be displayed or made accessible in application panel 960.


A connection panel 940 may include information associated with network connections and maintenance. For instance, the connection panel 940 may display the basic network start and end times and durations of network connectivity. The connection panel 940 may include a graphical representation of network up-time, network down-time, bandwidth availability, bandwidth use, max ping, average ping, packet loss, and/or other information associated with network connectivity between a telepresence device and a healthcare facility. Network information associated with a connection between two healthcare facilities may also be displayed and/or managed.


The connection panel 940 may additionally, or alternatively, display information associated with connection services configured to provide a reliable and robust peer-to-peer and/or server-based connection across a wide range of network types. For instance, the systems and methods described in U.S. patent application Ser. No. 11/801,491, filed on May 9, 2007, titled “ROBOT SYSTEM THAT OPERATES THROUGH A NETWORK FIREWALL,” which application is hereby incorporated by reference in its entirety, may be used in conjunction with the presently described systems and methods. The connection panel 940 may also display information associated with automatic bandwidth tests and/or general profiling of a network.



FIG. 10 illustrates a viewing level 1000 displaying the dynamic bandwidth management, latency, and packet loss during various time periods for one or more telepresence devices. Such a viewing level 1000 may be useful for a user to diagnose networking problems and/or improve a telepresence network.



FIG. 11 illustrates a viewing level 1100 of an application selected via the application panel 960 in FIG. 9. The exemplary information panels illustrated in FIG. 11 are associated with the application StrokeRESPOND. Any of a wide variety of application interfaces may be accessible via the visualization and management system described herein. As illustrated, information associated with strokes may be displayed in conjunction with the StrokeRESPOND application. For instance, the display may include a door-to-needle time 1150 corresponding to the amount of time between a patient's arrival at a healthcare facility and the time the patient receives clot-busting medication. The display may also include StrokeRESPOND statistics 1110, physician response times 1120, and/or t-PA contraindications and warning information 1140. A user may navigate to alternative viewing levels and/or return to the previous viewing level via the panel 1130.



FIG. 12 illustrates a viewing level 1200 showing the navigational paths 1230 and 1240 of a telepresence device 1210 on a plan map 1260 for a selected time period. According to various embodiments, the viewing level 1200 may be selected via the application panel 960 in FIG. 9, from within the detail request panel 460 of FIG. 4B, and/or from within any other viewing level. The viewing level 1200 may be selected based on a particular healthcare facility or based on a particular telepresence device 1210. In some embodiments, the viewing level 1200 showing the navigational paths 1230 and 1240 may be an independent program, application, or accessible website.


As illustrated, the plan map 1260 may include various hallways and rooms of a healthcare facility. In some embodiments, the number of rooms, hallways, and/or floors may justify a zoom selection tool, a panning selection tool, and/or a floor selection tool. According to various embodiments, the plan map 1260 may be displayed along with a time period selection menu 1220. A user may select a time period via the time period selection menu 1220. According to various embodiments, the time period may range from a few minutes to a few days. In the illustrated embodiment, a user may select a day from a calendar and a time from a slider bar. The user-selected time may constitute a lower bound of a selected time period. The upper bound may also be selected by the user, or, as illustrated, the upper bound may be the current date and time.


Navigational paths 1230 and 1240 of the telepresence device for the selected time period may be displayed on the plan map 1260. The visualization tool in viewing level 1200 may provide a user with a useful ability to distinguish between a navigational path 1230 in which the telepresence device 1210 was in a teleoperated drive mode, and a navigational path 1240 in which the telepresence device 1210 was in an autonomous drive mode. Additional drive modes, such as a hybrid drive mode, may also be distinguishable on the plan map 1260. Descriptions of various drive modes and systems and methods for implementing the same are described in U.S. patent application Ser. No. 13/360,579, filed on Jan. 27, 2012, titled “INTERFACING WITH A MOBILE TELEPRESENCE ROBOT,” which application is hereby incorporated by reference in its entirety.


In the illustrated embodiments, the navigational path 1230 in which the telepresence device 1210 was in a teleoperated drive mode is illustrated as a dashed line and the navigational path 1240 in which the telepresence device 1210 was in an autonomous drive mode is illustrated as a dash-dot-dot line. In practice, the navigational paths 1230 and 1240 representing different drive modes may be illustrated on the plan map 1260 as different colors, shades, line patterns, opacities, etc. In addition, intersections of multiple types of navigational paths 1230 and 1240 may be displayed side-by-side (as illustrated) or as a third line color, a particular line shading gradient, a line thickness, a line pattern, or a line hue. For example, if the navigational path 1230 in which the telepresence device 1210 was in a teleoperated drive mode is displayed as a red line and the navigational path 1240 in which the telepresence device 1210 was in an autonomous drive mode is illustrated as a blue line, the intersections of the two lines may be illustrated as purple lines. Such intersections may include long sections of hallways or rooms that the telepresence device 1210 traversed in more than one drive mode.


Additionally, the number of times the telepresence device 1210 traversed a particular section of the plan map 1260 may be displayed as well. For example, the thickness of a displayed navigational path may correspond to the number of times the telepresence device 1210 traversed the navigational path. In other embodiments, the number of times the telepresence device traversed a particular section of a navigational path in a particular drive mode may be visualized using various line colors, line shading gradients, line color gradients, line thicknesses, line patterns, line hues, numerical annotations, and/or symbolic annotations.


In some embodiments, the current location of the telepresence device 1210 may be displayed on the plan map 1260. In other embodiments, the location of the telepresence device may be displayed at a selected instantaneous time, displayed at an upper or lower bound of a selected time period, or selectively removed from display.



FIG. 13 illustrates a viewing level 1300 allowing a user to visualize telemetry data 1350 for a patient as a pop-up window on a plan map 1360 in a selected room 1330. Again, the viewing level 1300 may be selected via the application panel 960 in FIG. 9, from within the detail request panel 460 of FIG. 4B, and/or from within any other viewing level. The viewing level 1300 may be selected based on a particular healthcare facility or based on the telepresence device 1310. In some embodiments, viewing level 1300 may be an independent program, application, or accessible website.


As illustrated, the plan map 1360 may include various hallways and rooms of a healthcare facility. In some embodiments, the number of rooms, hallways, and/or floors may justify a zoom selection tool, a panning selection tool, and/or a floor selection tool (not illustrated); such navigation features may be added as is deemed useful for a particular application. According to various embodiments, the plan map 1360 may be displayed along with a time period selection menu 1320. A user may select a time via the time period selection menu 1320. In the illustrated embodiment, a user may select a day from a calendar and a time from a slider bar. Additionally, a user may select a room within the plan map 1360.


Telemetry data 1350 for a patient within the selected room at the selected time may be displayed as a pop-up window (or as a standalone window). The telemetry data 1350 may be collected and recorded by various monitoring and data collection systems, including the telepresence device 1310. The telemetry data 1350 may include data such as blood pressure, heart rate, temperature, respiration rate, and electrocardiogram information. The displayed telemetry data 1350 may be instantaneous telemetry data for the selected time. For example, the telemetry data may be displayed as instantaneous numerical values. The displayed telemetry data 1350 may include waveforms plotted over time. In such an embodiment, the waveform may include, begin with, be centered on, or end with the selected time.


A user may select a room in any of a wide variety of ways. For example, a user may select a room via a mouse-over 1340 held over the room 1330 for a predetermined amount of time. In alternative embodiments, mouse clicks, keyboard inputs, touch inputs, and/or other auxiliary selection inputs may be used to select a room on the plan map 1360.


In some embodiments, the viewing level 1300 of FIG. 13 and the viewing level 1200 of FIG. 12 may be combined into a single viewing level. In such an embodiment, a user may selectively view navigational paths of a telepresence device and/or telemetry data associated with a patient within a particular room.



FIG. 14 illustrates a table 1400 of patients and various associated data. Some of the various data points associated with each patient may be omitted, or additional data points may be included. In some embodiments, the table 1400 may be displayed directly to a user. Visualization of the data in table 1400 may be further enhanced using the visualization tools illustrated in FIGS. 15-20. The actual data within each category and the number of patients is merely exemplary. The data within each category may vary by hospital, by physician(s), by telepresence device, and/or by individual experiences. Moreover, larger data sets may more accurately reveal trends in the data. The data categories are described below from left to right across FIG. 14.


The table 1400 includes a patient identification 1401. The patient identification may be a name, a number, an alphanumeric string, or a pseudonym, and may identify gender, etc. Each patient may be ranked or assigned an outcome rating 1402. The outcome rating may be assigned automatically based on a predefined set of criteria, or may be input by a nurse, doctor, or other medical practitioner. The outcome rating may be a daily rating, an average rating for a given time period, or an outcome rating for a discharged patient. In one example, the outcome rating corresponds to a practitioner-assigned rating given to each patient as the patient is discharged. In one embodiment, the outcome rating is a numerical value ranging from 0 (death) to 100 (full recovery). Ratings between 0 and 100 may be subjective or objectively assigned based on a predetermined set of criteria.


The data may include a primary physician 1403. The primary physician may be the primary physician assigned to the patient at a time the outcome rating was assigned, or the primary physician of the patient based on the total amount of time a physician cared for the patient. In some embodiments, a patient may have a local primary physician and a remote primary physician. The primary physician 1403 listed on the table 1400 may be the physician who most used the telepresence device to treat the patient. The data may include a primary condition 1404 as well. The primary condition 1404 may be a general category describing the condition for which the patient is being treated. In some embodiments, the patient may have multiple primary conditions 1404.


The data may also include a room number 1405 of the patient and the number of visits made each day by a telepresence device 1406. Information about the usage of a telepresence device accessory, such as the number of times a stethoscope of the telepresence device is used 1407, may also be included. Telepresence device accessories may include any of a wide variety of accessory devices configured to measure a physiological parameter. Measuring a physiological parameter may include a remote practitioner viewing a sonogram screen as a sonogram device is used on a patient. Additional examples of accessories that may be used via a telepresence device include accessories configured to determine blood pressure, heart rate, temperature, respiration rate, and electrocardiogram information. Any of a wide variety of instruments and visualization tools may be incorporated as accessories to a telepresence device, and the usage of the same may be included as data points in the table 1400.


Information associated with camera usage may also be included. For example, the amount of time a camera of the telepresence device is zoomed to 50% or greater 1408, the amount of time the camera of the telepresence device is used to look at the patient 1409, the amount of time the camera of the telepresence device is used to look at staff for the patient 1410, the amount of time the camera of the telepresence device is used to look at a monitor for a patient 1411, and/or the amount of time the camera of the telepresence device is used to look at charts for the patient 1412 may be included in table 1400. The data may also include the amount of time the camera of the telepresence device is used to look at other things 1413. Whether the camera of the telepresence device is being used to look at a patient, a family member, staff, charts, monitors, or other things could be determined using one or more image analysis or computer vision techniques. For example, this functionality could be accomplished using Haar-like feature detection to identify faces. Patients, who may be in a prostrate position, may be distinguished from family and staff using height or skeletal mapping to identify probable body position. Additionally, feature detection algorithms such as scale-invariant feature transform (SIFT) may be used to identify hospital attire for distinguishing hospital personnel. SIFT-based feature detection may also be used to identify screens and charts.


The data may also include the amount of time the telepresence device is in the room of the patient 1414, the amount of time the telepresence device is at the bedside of the patient 1415, and/or the amount of time the telepresence device spends driving 1416. This data may be filtered such that the amount of time the telepresence device is in the room does not include the amount of time the telepresence device is at the patient's bedside, even though the telepresence device was necessarily within the patient's room when it was at the patient's bedside.


An analysis of the data above may also enable a user to discover usage trends for a telepresence device that result in the most positive outcome ratings. For example, it may be discovered that the number of visits by a telepresence device per day correlates to positive patient ratings. The following description of FIGS. 15-20 illustrates various examples of potential visualization parameters that allow for the data of numerous patients to be visually presented in a useful manner to a user. It may be appreciated that an exhaustive table of thousands of patients may be difficult for a user to process. However, a graphical visualization tool may allow a user to quickly discover correlations and associations between the usage of a telepresence device and patient well-being.



FIG. 15 illustrates a coordinate system 1510 including selected graphs 1520 of patient outcome ratings and various telepresence device statistics associated with the patients. As illustrated, the viewing level 1500 includes the coordinate system 1510, with various graphs 1520, and a legend 1530. The horizontal axis of each of the coordinate systems in FIGS. 15-20 is labeled with the identification numbers of each of a plurality of patients. Accordingly, graphs 1520 are graphed with respect to each patient. In some embodiments, the graphs may be graphed as scatterplots, accurately reflecting the discrete number of patients. In other embodiments, line graphs may be extrapolated from the available data, and/or another type of graph, such as a bar graph, may be utilized. Viewing level 1500 may further include a telepresence device statistic selection panel 1540 allowing a user to selectively display graphs for any number of telepresence device statistics.


The telepresence device statistics may include any of a wide variety of informational data associated with the usage of a telepresence device for a particular patient. In the illustrated embodiments, the selectable telepresence device statistics include (from top to bottom) the number of visits made by the telepresence device per day, the number of stethoscope usages during a certain time period (it may be the entire time the patient was being treated), the amount of time a camera of the telepresence device is zoomed to 50% or more, the amount of time the camera of the telepresence device is used to look at a patient, the amount of time the camera of the telepresence device is used to look at staff, the amount of time the camera of the telepresence device is used to look at monitors or charts, the amount of time the telepresence device is in the patient's room, the amount of time the telepresence device is at the patient's bedside, and the amount of time the telepresence device is driving for the patient. Additional telepresence device statistics may be included in the telepresence device statistic selection panel 1540, and/or some of the listed statistics may be omitted. Similar abbreviations for the various telepresence device statistics 1540 are used throughout FIGS. 15-20. A filter selection panel 1550 is set to “all” in FIG. 15.



FIG. 15 illustrates a coordinate system 1510 including selected graphs 1520 corresponding to the checked boxes in the telepresence device statistic selection panel 1540. The graphs 1520 indicate that the amount of time a camera of a telepresence device is used to look at monitors/charts may correspond to the outcome ranking of a patient. It will be appreciated that similar data in a table form may be difficult to analyze for a user, while the visualization techniques and tools described herein may facilitate rapid and improved data analysis in a selective graphical form.



FIG. 16 illustrates viewing level 1600 including a coordinate system 1610 with a number of selected graphs 1620, including an outcome rating for each patient, the number of visits by a telepresence device each day to each patient, and the number of stethoscope usages for each patient. A legend 1630 may facilitate review of the coordinate system 1610. In the illustrated examples, graphs 1620 are distinguishable based on different line patterns (dashes). In practice, each graph 1620 may be distinguishable using various line colors, line shading gradients, line color gradients, line thicknesses, line patterns, line hues, numerical annotations, and/or symbolic annotations.


The graphs 1620 may indicate that the number of visits per day by a telepresence device may positively correspond to an outcome rating of a patient. A user may visualize the coordinate system 1610 and determine that a telepresence device should visit each patient more frequently. The viewing level 1600 includes only the number of visits per day and the number of stethoscope usages selected via telepresence device statistic selection panel 1640. The viewing level 1600 does not include any filtering via filter selection panel 1650.



FIG. 17 illustrates a viewing level 1700 including a coordinate system 1710 with graphs 1720 of patient outcome ratings, a number of visits per day, and a number of stethoscope uses, as can be seen in legend 1730. Accordingly, the graphs 1720 of FIG. 17 are the same as in FIG. 16; i.e., the selections made via telepresence device statistic selection panels 1740 and 1640 are the same. However, in FIG. 17, a condition filter is applied via filter selection panel 1750. The graphs 1720 of FIG. 17 are filtered to include only the data for patients whose primary condition is respiratory in nature.


Comparing FIGS. 16 and 17, it can be seen that the number of stethoscope uses in with patients whose primary condition is respiratory in nature correlates with the outcome ratings (FIG. 17), while the number of stethoscope uses in patients with all types of conditions (unfiltered) does not correlate with the outcome ratings (FIG. 16). Accordingly, it may be useful to adjust the condition, primary physician, and room number filters available in filter selection panel 1750 in order to facilitate the discovery of additional correlations within the data sets.



FIG. 18A illustrates a viewing level 1800 including a coordinate system 1810 with graphs 1820. Graphs 1820 include an outcome rating and the amount of time a camera of a telepresence device is zoomed greater than 50%, as illustrated in the legend 1830. The filters in filter selection panel 1850 are set to “all.” As can be seen in FIG. 18A, there does not seem to be a correlation between the amount of time the camera of the telepresence device is zoomed greater than 50% and the outcome rating of the patient.


However, looking at FIG. 18B, it can be seen that by applying a condition filter within the filter selection panel 1850 to visualize only those patients whose primary condition is neurological in nature, a correlation between camera usage and outcome rating can be seen. Accordingly, graphs 1821 illustrate that for patients with neurological conditions, using the camera of a telepresence device zoomed to 50% or greater is correlated to the outcome rating of the patient.



FIG. 19 illustrates a viewing level 1900 with a coordinate system 1910 that includes numerous graphs 1920 selected via the telepresence device statistic selection panel 1940. Each of the graphs 1920 is described in the legend 1930. A physician filter may be applied via the filter selection panel 1950. Accordingly, data associated with a particular physician is graphed. An unfiltered visibility slider 1980 may allow the complete set of data to be partially visible. This may allow a user to visualize the data of a particular physician with respect to all other physicians. Accordingly, graphs 1920 include data associated with the selected physician in bold, and the complete set of data in a thinner line. The same line pattern (dashes) is used for each telepresence device statistic. In various embodiments, the unfiltered visibility slider 1980 may allow a user to select an opacity percentage between 0 and 100. The graphs 1920 may be distinguishable using various line colors, line shading gradients, line color gradients, line thicknesses, line patterns, line hues, numerical annotations, and/or symbolic annotations.



FIG. 20 illustrates a viewing level 2000 with a coordinate system 2010 that includes numerous graphs 2020 selected via the telepresence device statistic selection panel 2040. Each of the graphs 2020 may be described in the legend 2030. A room number filter may be applied via the filter selection panel 2050. Accordingly, data associated with patients who stayed in a particular room is graphed in graphs 2020. An unfiltered visibility slider 2080 may allow data for the selected room to be compared with that of all of the rooms, with the data associated with all of the rooms shown as slightly translucent, with thinner lines, with different hues, and/or the like. Such a viewing level 2000 may allow a user to determine which rooms have the highest success rate. It may be that rooms closest to a docking station of a telepresence device have a higher rate of visits by the telepresence device and, accordingly, a higher outcome rating. The presently described visualization tool may allow a user to quickly and easily filter, organize, and selectively display numerous data points in order to determine correlations that may improve overall medical care in a healthcare facility.



FIG. 21 illustrates a functional block diagram of a computer system 2100 including various modules 2170 for a telepresence network visualization and management system. As illustrated, computer system 2100 may include a processor 2130, memory (such as RAM) 2140, and a network interface 2150 connected via a bus 2120. The bus 2120 may also connect a computer-readable storage medium 2170. The computer-readable storage medium 2170 may include various modules, such as a display module 2180, a viewing level request module 2182, a navigation request module 2184, a device detail request module 2186, a connection rule module 2188, and a healthcare network detail request module 2190. Additional modules may be included, or some modules may be omitted, in order for a computer system to perform any of the server-side or client-side functions of the various systems and methods described herein.


The display module 2180 may be configured to display a viewing level of a telepresence network on a geographical representation. Display module 2180 may be configured to display any of the various viewing levels described herein, including the various selection panels, filtering panels, and graphical representations. The viewing level request module 2182 may be configured to receive a viewing request to cause the display module 2180 to provide a second viewing level. The navigation request module 2184 may be configured to receive a navigational request to navigate within the geographical representation.


The device detail request module 2186 may be configured to receive a detail request to cause the display module 2180 to display a third viewing level, the third viewing level including information associated with one or more telepresence devices. The connection rule module 2188 may be configured to allow for the management of a connection rule governing telepresence devices. The healthcare network detail request module 2190 may be configured to receive a healthcare network detail request to cause the display module 2180 to display a fourth viewing level, the fourth viewing level including information associated with healthcare facilities.


A navigation path display module 2192 may be configured to display navigational paths traversed by a telepresence device on a plan map. The navigational paths may be displayed in such a way that they are distinguishable based on drive mode, as described herein. A time selection module 2194 may be configured to allow a user to specify a time or time period. The time selection module 2194 may receive user input via a calendar, a clock, a slider, numerical inputs, and/or the like. A telemetry display module 2196 may be configured to display historical and/or current telemetry data for a selected time or time period for a selected room on a plan map.


A graphing, selection, and filtering module 2198 may be configured to provide graphical views and receive selection inputs and filtering inputs as described in conjunction with FIGS. 14-20. The graphs produced by graphing, selection, and filtering module 2198 may be locally rendered or remotely rendered, and may be stored in memory 2140 or rendered in real-time by processor 2130 or another processor (such as a specialized processor). Any of the described viewing levels, communications systems, inputs, and modules may be implemented in any combination of hardware, firmware, and software. Moreover, one or more functions may be performed remotely or stored remotely as is found useful.


Many changes may be made to the details of the above-described embodiments without departing from the underlying principles and scope of the present disclosure. Accordingly, the scope of the presently described systems and methods should be determined only by the following claims.

Claims
  • 1. A computer program product, comprising a non-transitory computer-readable-medium having executable computer program code, the computer program code configured to cause a computer to: receive a plurality of telepresence device statistics, each telepresence device statistic comprising information associated with the use of a telepresence device in a healthcare network comprising a plurality of telepresence devices coupled to a network;display a telepresence device statistic selection panel configured to allow a user to select one or more of the plurality of telepresence device statistics;receive a selection of at least one telepresence device statistic via the telepresence device statistic selection panel; anddisplay a visual representation of the selected at least one telepresence device statistic, wherein the plurality of telepresence device statistics comprises a telepresence device statistic indicating how many sessions were conducted using the telepresence device during specified a time period.
  • 2. The computer program product of claim 1, the computer program code is further configured to cause the computer to: receive a rating for each of the plurality of patients treated via a telepresence device, the ratings associated with a health aspect of each of the plurality of patients; andwherein to display the visual representation the computer program code is further configured to cause the computer to: display a graph of the at least one selected telepresence device statistic with respect to each of the plurality of patients on a coordinate system; anddisplay an indication of the rating for each of the plurality of patients with respect to each of the plurality of patients displayed on the coordinate system.
  • 3. The computer program product of claim 2, wherein the rating for each of the plurality of patients comprises an outcome rating corresponding to a health aspect of a discharged patient.
  • 4. The computer program product of claim 1, wherein the computer program code is further configured to cause a computer to: receive a primary patient condition for each of the plurality of patients;display a filter selection panel comprising a condition filter input, the condition filter input configured to allow a user to select one or more primary patient conditions;receive at least one selection via the filter selection panel;remove from visual representation any telepresence device statistic not associated with the selections made via the filter selection panel; andupdate the visual representation of the at least one selected telepresence device statistic based on the selections made via the filter selection panel.
  • 5. The computer program product of claim 1, wherein the computer program code is further configured to cause a computer to: receive information identifying a primary physician for each of the plurality of patients;display a filter selection panel comprising a primary physician filter input, the primary physician filter input configured to allow a user to select one or more primary physicians;receive at least one selection via the filter selection panel;remove from the visual representation any of the telepresence device statistics not associated with the at least one selection made via the filter selection panel; andupdate the visual representation of the at least one selected telepresence device statistic based on the selections made via the filter selection panel.
  • 6. The computer program product of claim 1, wherein the computer program code is further configured to cause a computer to: receive information identifying a room associated with each of the plurality of patients;display a filter selection panel comprising a room filter input, the room filter input configured to allow a user to select one or more rooms of a healthcare facility;receive at least one selection via the filter selection panel;remove from the visual representation any of the plurality of patients not associated with the at least one selection made via the filter selection panel; andupdate the visual representation of the at least one selected telepresence device statistic based on the selections made via the filter selection panel.
  • 7. The computer program product of claim 1, wherein the plurality of telepresence device statistics comprises a telepresence device statistic indicating how many visits were made to each of the plurality of patients by the telepresence device during a time period.
  • 8. The computer program product of claim 1, wherein the plurality of telepresence device statistics comprises a telepresence device statistic associated with a usage of a telepresence device accessory on each of the plurality of patients during a time period, the telepresence device statistic configured to measure a physiological parameter.
  • 9. The computer program product of claim 8, wherein the telepresence device accessory is configured to determine one of a blood pressure, a heart rate, a temperature, a respiration rate, and electrocardiogram information.
  • 10. The computer program product of claim 8, wherein the telepresence device accessory comprises one of a stethoscope, an otoscope, and a medical imaging device.
  • 11. The computer program product of claim 1, wherein the plurality of telepresence device statistics comprises a telepresence device statistic associated with a usage of a camera of the telepresence device during a time period.
  • 12. The computer program product of claim 1, wherein the plurality of telepresence device statistics comprises a telepresence device statistic associated with a location of the telepresence device relative to each of the plurality of patients during a time period.
US Referenced Citations (825)
Number Name Date Kind
3821995 Aghnides Jul 1974 A
4107689 Jellinek Aug 1978 A
4213182 Eichelberger et al. Jul 1980 A
4413693 Derby Nov 1983 A
4471354 Smith Sep 1984 A
4519466 Shiraishi May 1985 A
4553309 Hess et al. Nov 1985 A
4572594 Schwartz Feb 1986 A
4625274 Schroeder Nov 1986 A
4638445 Mattaboni Jan 1987 A
4652204 Arnett Mar 1987 A
4669168 Tamura et al. Jun 1987 A
4679152 Perdue Jul 1987 A
4697278 Fleischer Sep 1987 A
4697472 Hiyane Oct 1987 A
4709265 Silverman et al. Nov 1987 A
4733737 Falamak Mar 1988 A
4751658 Kadonoff et al. Jun 1988 A
4766581 Korn et al. Aug 1988 A
4777416 George et al. Oct 1988 A
4797557 Ohman Jan 1989 A
4803625 Fu et al. Feb 1989 A
4847764 Halvorson Jul 1989 A
4875172 Kanayama Oct 1989 A
4878501 Shue Nov 1989 A
4942512 Kohno Jul 1990 A
4942538 Yuan et al. Jul 1990 A
4953159 Hayden et al. Aug 1990 A
4974607 Miwa Dec 1990 A
4977971 Crane et al. Dec 1990 A
5006988 Borenstein et al. Apr 1991 A
5040116 Evans et al. Aug 1991 A
5051906 Evans et al. Sep 1991 A
5073749 Kanayama Dec 1991 A
5084828 Kaufman et al. Jan 1992 A
5130794 Ritchey Jul 1992 A
5148591 Pryor Sep 1992 A
5153833 Gordon et al. Oct 1992 A
5155684 Burke et al. Oct 1992 A
5157491 Kassatly Oct 1992 A
5182641 Diner et al. Jan 1993 A
5186270 West Feb 1993 A
5193143 Kaemmerer et al. Mar 1993 A
5217453 Wilk Jun 1993 A
5220263 Onishi et al. Jun 1993 A
5224157 Yamada et al. Jun 1993 A
5230023 Nakano Jul 1993 A
5231693 Backes et al. Jul 1993 A
5236432 Matsen et al. Aug 1993 A
5262944 Weisner et al. Nov 1993 A
5305427 Nagata Apr 1994 A
5315287 Sol May 1994 A
5319611 Korba Jun 1994 A
5341242 Gilboa et al. Aug 1994 A
5341459 Backes Aug 1994 A
5341854 Zezulka et al. Aug 1994 A
5347306 Nitta Sep 1994 A
5347457 Tanaka et al. Sep 1994 A
5350033 Kraft Sep 1994 A
5366896 Margrey et al. Nov 1994 A
5374879 Pin et al. Dec 1994 A
5375195 Johnston Dec 1994 A
5400068 Ishida et al. Mar 1995 A
5417210 Funda et al. May 1995 A
5419008 West May 1995 A
5436542 Petelin et al. Jul 1995 A
5441042 Putman Aug 1995 A
5441047 David et al. Aug 1995 A
5442728 Kaufman et al. Aug 1995 A
5462051 Oka et al. Oct 1995 A
5486853 Baxter et al. Jan 1996 A
5510832 Garcia Apr 1996 A
5511147 Abdel-Malek Apr 1996 A
5528289 Cortjens et al. Jun 1996 A
5539741 Barraclough et al. Jul 1996 A
5544649 David et al. Aug 1996 A
5550577 Verbiest et al. Aug 1996 A
5553609 Chen et al. Sep 1996 A
5563998 Yaksich et al. Oct 1996 A
5572229 Fisher Nov 1996 A
5572999 Funda et al. Nov 1996 A
5594859 Palmer et al. Jan 1997 A
5600573 Hendricks et al. Feb 1997 A
5617539 Ludwig et al. Apr 1997 A
5619341 Auyeung et al. Apr 1997 A
5623679 Rivette et al. Apr 1997 A
5630566 Case May 1997 A
5636218 Ishikawa et al. Jun 1997 A
5652849 Conway et al. Jul 1997 A
5657246 Hogan et al. Aug 1997 A
5659779 Laird et al. Aug 1997 A
5673082 Wells et al. Sep 1997 A
5675229 Thorne Oct 1997 A
5682199 Lankford Oct 1997 A
5684695 Bauer Nov 1997 A
5701904 Simmons et al. Dec 1997 A
5734805 Isensee et al. Mar 1998 A
5739657 Takayama et al. Apr 1998 A
5748629 Caldara et al. May 1998 A
5749058 Hashimoto May 1998 A
5749362 Funda et al. May 1998 A
5754631 Cave May 1998 A
5758079 Ludwig et al. May 1998 A
5762458 Wang et al. Jun 1998 A
5764731 Yablon Jun 1998 A
5767897 Howell Jun 1998 A
5786846 Hiroaki Jul 1998 A
5787545 Colens Aug 1998 A
5793365 Tang et al. Aug 1998 A
5801755 Echerer Sep 1998 A
5802494 Kuno Sep 1998 A
5836872 Kenet et al. Nov 1998 A
5838575 Lion Nov 1998 A
5844599 Hildin Dec 1998 A
5857534 Devault et al. Jan 1999 A
5867494 Krishnaswamy et al. Feb 1999 A
5867653 Aras et al. Feb 1999 A
5871451 Unger et al. Feb 1999 A
5872922 Hogan et al. Feb 1999 A
5876325 Mizuno et al. Mar 1999 A
5911036 Wright et al. Jun 1999 A
5917958 Nunally et al. Jun 1999 A
5927423 Wada et al. Jul 1999 A
5949758 Kober Sep 1999 A
5954692 Smith et al. Sep 1999 A
5959423 Nakanishi et al. Sep 1999 A
5961446 Beller et al. Oct 1999 A
5966130 Benman, Jr. Oct 1999 A
5973724 Riddle Oct 1999 A
5974446 Sonnenreich et al. Oct 1999 A
5983263 Rothrock et al. Nov 1999 A
5995119 Cosatto et al. Nov 1999 A
5995884 Allen et al. Nov 1999 A
5999977 Riddle Dec 1999 A
6006946 Williams et al. Dec 1999 A
6031845 Walding Feb 2000 A
6036812 Williams et al. Mar 2000 A
6047259 Campbell et al. Apr 2000 A
6091219 Maruo et al. Jul 2000 A
6113343 Goldenberg et al. Sep 2000 A
6133944 Braun et al. Oct 2000 A
6135228 Asada et al. Oct 2000 A
6148100 Anderson et al. Nov 2000 A
6160582 Hill Dec 2000 A
6170929 Wilson et al. Jan 2001 B1
6175779 Barrett Jan 2001 B1
6189034 Riddle Feb 2001 B1
6201984 Funda et al. Mar 2001 B1
6211903 Bullister Apr 2001 B1
6219587 Ahlin et al. Apr 2001 B1
6232735 Baba et al. May 2001 B1
6233504 Das et al. May 2001 B1
6233735 Ebihara May 2001 B1
6250928 Poggio et al. Jun 2001 B1
6256556 Zenke Jul 2001 B1
6259806 Green Jul 2001 B1
6259956 Myers et al. Jul 2001 B1
6266162 Okamura et al. Jul 2001 B1
6266577 Popp et al. Jul 2001 B1
6289263 Mukherjee Sep 2001 B1
6292713 Jouppi et al. Sep 2001 B1
6292714 Okabayashi Sep 2001 B1
6304050 Skaar et al. Oct 2001 B1
6314631 Pryor Nov 2001 B1
6317652 Osada Nov 2001 B1
6317953 Pryor Nov 2001 B1
6321137 De Smet Nov 2001 B1
6324184 Hou et al. Nov 2001 B1
6324443 Kurakake et al. Nov 2001 B1
6325756 Webb et al. Dec 2001 B1
6327516 Zenke Dec 2001 B1
6330486 Padula Dec 2001 B1
6330493 Takahashi et al. Dec 2001 B1
6346950 Jouppi Feb 2002 B1
6346962 Goodridge Feb 2002 B1
6369847 James et al. Apr 2002 B1
6373855 Downing et al. Apr 2002 B1
6381515 Inoue et al. Apr 2002 B1
6389329 Colens May 2002 B1
6400378 Snook Jun 2002 B1
6408230 Wada Jun 2002 B2
6411055 Fujita et al. Jun 2002 B1
6430471 Kintou et al. Aug 2002 B1
6430475 Okamoto et al. Aug 2002 B2
6438457 Yokoo et al. Aug 2002 B1
6445964 White et al. Sep 2002 B1
6449762 Mcelvain Sep 2002 B1
6452915 Jorgensen Sep 2002 B1
6457043 Kwak et al. Sep 2002 B1
6459955 Bartsch et al. Oct 2002 B1
6463352 Tadokoro et al. Oct 2002 B1
6463361 Wang et al. Oct 2002 B1
6466844 Ikeda et al. Oct 2002 B1
6468265 Evans et al. Oct 2002 B1
6470235 Kasuga et al. Oct 2002 B2
6474434 Bech Nov 2002 B1
6480762 Uchikubo et al. Nov 2002 B1
6491701 Tierney et al. Dec 2002 B2
6496099 Wang et al. Dec 2002 B2
6496755 Wallach et al. Dec 2002 B2
6501740 Sun et al. Dec 2002 B1
6507773 Parker et al. Jan 2003 B2
6522906 Salisbury et al. Feb 2003 B1
6523629 Buttz et al. Feb 2003 B1
6526332 Sakamoto et al. Feb 2003 B2
6529620 Thompson Mar 2003 B2
6529765 Franck et al. Mar 2003 B1
6529802 Kawakita et al. Mar 2003 B1
6532404 Colens Mar 2003 B2
6535182 Stanton Mar 2003 B2
6535793 Allard Mar 2003 B2
6540039 Yu et al. Apr 2003 B1
6543899 Covannon et al. Apr 2003 B2
6549215 Jouppi Apr 2003 B2
6563533 Colby May 2003 B1
6567038 Granot et al. May 2003 B1
6580246 Jacobs Jun 2003 B2
6581798 Liff et al. Jun 2003 B2
6584376 Van Kommer Jun 2003 B1
6587750 Gerbi et al. Jul 2003 B2
6590604 Tucker et al. Jul 2003 B1
6594269 Polcyn Jul 2003 B1
6594552 Nowlin et al. Jul 2003 B1
6597392 Jenkins et al. Jul 2003 B1
6602469 Maus et al. Aug 2003 B1
6604019 Ahlin et al. Aug 2003 B2
6604021 Imai et al. Aug 2003 B2
6611120 Song et al. Aug 2003 B2
6643496 Shimoyama et al. Nov 2003 B1
6646677 Noro et al. Nov 2003 B2
6650748 Edwards et al. Nov 2003 B1
6666374 Green et al. Dec 2003 B1
6667592 Jacobs et al. Dec 2003 B2
6674259 Norman et al. Jan 2004 B1
6684129 Salisbury et al. Jan 2004 B2
6691000 Nagai et al. Feb 2004 B2
6693585 Macleod Feb 2004 B1
6710797 Mcnelley et al. Mar 2004 B1
6724823 Rovati et al. Apr 2004 B2
6728599 Wang et al. Apr 2004 B2
6763282 Glenn et al. Jul 2004 B2
6764373 Osawa et al. Jul 2004 B1
6769771 Trumbull Aug 2004 B2
6781606 Jouppi Aug 2004 B2
6784916 Smith Aug 2004 B2
6785589 Eggenberger et al. Aug 2004 B2
6791550 Goldhor et al. Sep 2004 B2
6798753 Doganata et al. Sep 2004 B1
6799065 Niemeyer Sep 2004 B1
6799088 Wang et al. Sep 2004 B2
6804580 Stoddard et al. Oct 2004 B1
6804656 Rosenfeld et al. Oct 2004 B1
6810411 Coughlin et al. Oct 2004 B1
6816192 Nishikawa Nov 2004 B1
6816754 Mukai et al. Nov 2004 B2
6836703 Wang et al. Dec 2004 B2
6839612 Sanchez et al. Jan 2005 B2
6840904 Goldberg Jan 2005 B2
6845297 Allard Jan 2005 B2
6852107 Wang et al. Feb 2005 B2
6853878 Hirayama et al. Feb 2005 B2
6853880 Sakagami et al. Feb 2005 B2
6871117 Wang et al. Mar 2005 B2
6879879 Jouppi et al. Apr 2005 B2
6888333 Laby May 2005 B2
6892112 Wang et al. May 2005 B2
6893267 Yueh May 2005 B1
6895305 Lathan et al. May 2005 B2
6898484 Lemelson et al. May 2005 B2
6914622 Smith et al. Jul 2005 B1
6925357 Wang et al. Aug 2005 B2
6951535 Ghodoussi et al. Oct 2005 B2
6952470 Tioe et al. Oct 2005 B1
6957712 Song et al. Oct 2005 B2
6958706 Chaco et al. Oct 2005 B2
6965394 Gutta et al. Nov 2005 B2
6990112 Brent et al. Jan 2006 B1
6995664 Darling Feb 2006 B1
7007235 Hussein et al. Feb 2006 B1
7011538 Chang Mar 2006 B2
7015934 Toyama et al. Mar 2006 B2
RE39080 Johnston Apr 2006 E
7030757 Matsuhira et al. Apr 2006 B2
7053578 Diehl et al. May 2006 B2
7055210 Keppler et al. Jun 2006 B2
7058689 Parker et al. Jun 2006 B2
7092001 Schulz Aug 2006 B2
7096090 Zweig Aug 2006 B1
7115102 Abbruscato Oct 2006 B2
7117067 Mclurkin et al. Oct 2006 B2
7123285 Smith et al. Oct 2006 B2
7123974 Hamilton Oct 2006 B1
7123991 Graf et al. Oct 2006 B2
7127325 Nagata et al. Oct 2006 B2
7129970 James et al. Oct 2006 B2
7133062 Castles et al. Nov 2006 B2
7142945 Wang et al. Nov 2006 B2
7142947 Wang et al. Nov 2006 B2
7151982 Liff et al. Dec 2006 B2
7154526 Foote et al. Dec 2006 B2
7155306 Haitin et al. Dec 2006 B2
7156809 Quy Jan 2007 B2
7158859 Wang et al. Jan 2007 B2
7158860 Wang et al. Jan 2007 B2
7158861 Wang et al. Jan 2007 B2
7161322 Wang et al. Jan 2007 B2
7162338 Goncalves et al. Jan 2007 B2
7164969 Wang et al. Jan 2007 B2
7164970 Wang et al. Jan 2007 B2
7167448 Wookey et al. Jan 2007 B2
7171286 Wang et al. Jan 2007 B2
7174238 Zweig Feb 2007 B1
7181455 Wookey et al. Feb 2007 B2
7184559 Jouppi Feb 2007 B2
7188000 Chiappetta et al. Mar 2007 B2
7199790 Rosenberg et al. Apr 2007 B2
7202851 Cunningham et al. Apr 2007 B2
7206627 Abovitz et al. Apr 2007 B2
7215786 Nakadai et al. May 2007 B2
7219364 Bolle et al. May 2007 B2
7222000 Wang et al. May 2007 B2
7227334 Yang et al. Jun 2007 B2
7256708 Rosenfeld et al. Aug 2007 B2
7262573 Wang et al. Aug 2007 B2
7283153 Provost et al. Oct 2007 B2
7289883 Wang et al. Oct 2007 B2
7292257 Kang et al. Nov 2007 B2
7292912 Wang et al. Nov 2007 B2
7305114 Wolff et al. Dec 2007 B2
7317685 Flott et al. Jan 2008 B1
7321807 Laski Jan 2008 B2
7332890 Cohen et al. Feb 2008 B2
7333642 Green Feb 2008 B2
7346429 Goldenberg et al. Mar 2008 B2
7352153 Yan Apr 2008 B2
7363121 Chen et al. Apr 2008 B1
7382399 Mccall et al. Jun 2008 B1
7386730 Uchikubo Jun 2008 B2
7391432 Terada Jun 2008 B2
7400578 Guthrie et al. Jul 2008 B2
7404140 ORourke Jul 2008 B2
7421470 Ludwig et al. Sep 2008 B2
7430209 Porter Sep 2008 B2
7432949 Remy et al. Oct 2008 B2
7433921 Ludwig et al. Oct 2008 B2
7441953 Banks Oct 2008 B2
7467211 Herman et al. Dec 2008 B1
7483867 Ansari et al. Jan 2009 B2
7492731 Hagendorf Feb 2009 B2
7510428 Obata et al. Mar 2009 B2
7523069 Friedl et al. Apr 2009 B1
7525281 Koyanagi et al. Apr 2009 B2
7535486 Motomura et al. May 2009 B2
7557758 Rofougaran Jul 2009 B2
7587260 Bruemmer et al. Sep 2009 B2
7587512 Ta et al. Sep 2009 B2
7590060 Miceli Sep 2009 B2
7593030 Wang et al. Sep 2009 B2
7599290 Dos Remedios et al. Oct 2009 B2
7624166 Foote et al. Nov 2009 B2
7630314 Dos Remedios et al. Dec 2009 B2
7631833 Ghaleb et al. Dec 2009 B1
7643051 Sandberg et al. Jan 2010 B2
7647320 Mok et al. Jan 2010 B2
7657560 Dirienzo Feb 2010 B1
7680038 Gourlay Mar 2010 B1
7693757 Zimmerman Apr 2010 B2
7698432 Short et al. Apr 2010 B2
7703113 Dawson Apr 2010 B2
7719229 Kaneko et al. May 2010 B2
7737993 Kaasila et al. Jun 2010 B2
7739383 Short et al. Jun 2010 B1
7756614 Jouppi Jul 2010 B2
7761185 Wang et al. Jul 2010 B2
7769492 Wang et al. Aug 2010 B2
7769705 Luechtefeld Aug 2010 B1
7774158 Domingues Goncalves et al. Aug 2010 B2
7813836 Wang et al. Oct 2010 B2
7831575 Trossell et al. Nov 2010 B2
7835775 Sawayama et al. Nov 2010 B2
7860680 Arms et al. Dec 2010 B2
7861366 Hahm et al. Jan 2011 B2
7885822 Akers et al. Feb 2011 B2
7890382 Robb et al. Feb 2011 B2
7912583 Gutmann et al. Mar 2011 B2
RE42288 Degioanni Apr 2011 E
7924323 Walker et al. Apr 2011 B2
7949616 Levy et al. May 2011 B2
7956894 Akers et al. Jun 2011 B2
7957837 Ziegler et al. Jun 2011 B2
7982763 King Jul 2011 B2
7982769 Jenkins et al. Jul 2011 B2
7987069 Rodgers et al. Jul 2011 B2
8077963 Wang et al. Dec 2011 B2
8116910 Walters et al. Feb 2012 B2
8126960 Obradovich et al. Feb 2012 B2
8170241 Roe et al. May 2012 B2
8179418 Wright et al. May 2012 B2
8180486 Saito et al. May 2012 B2
8209051 Wang et al. Jun 2012 B2
8212533 Ota Jul 2012 B2
8265793 Cross et al. Sep 2012 B2
8287522 Moses et al. Oct 2012 B2
8292807 Perkins et al. Oct 2012 B2
8320534 Kim et al. Nov 2012 B2
8340654 Bratton et al. Dec 2012 B2
8340819 Mangaser et al. Dec 2012 B2
8348675 Dohrmann Jan 2013 B2
8374171 Cho et al. Feb 2013 B2
8400491 Panpaliya et al. Mar 2013 B1
8401275 Wang et al. Mar 2013 B2
8423284 O Shea Apr 2013 B2
8451731 Lee et al. May 2013 B1
8463435 Herzog et al. Jun 2013 B2
8489641 Seefeld et al. Jul 2013 B1
8503340 Xu Aug 2013 B1
8515577 Wang et al. Aug 2013 B2
8527094 Kumar et al. Sep 2013 B2
8532860 Daly Sep 2013 B2
8610786 Ortiz Dec 2013 B2
8612051 Norman et al. Dec 2013 B2
8639797 Pan et al. Jan 2014 B1
8666771 Roesch et al. Mar 2014 B2
8670017 Stuart et al. Mar 2014 B2
8726454 Gilbert et al. May 2014 B2
8750906 Winkler et al. Jun 2014 B2
8776043 Thimsen et al. Jul 2014 B1
8836751 Ballantyne et al. Sep 2014 B2
8849679 Wang et al. Sep 2014 B2
8849680 Wright et al. Sep 2014 B2
8861750 Roe et al. Oct 2014 B2
8897920 Wang et al. Nov 2014 B2
8902278 Pinter et al. Dec 2014 B2
8965990 Mallet et al. Feb 2015 B2
9224181 Pinter et al. Dec 2015 B2
9251313 Ross et al. Feb 2016 B2
20010002448 Wilson et al. May 2001 A1
20010010053 Ben-Shachar et al. Jul 2001 A1
20010020200 Das et al. Sep 2001 A1
20010034475 Flach et al. Oct 2001 A1
20010034544 Mo Oct 2001 A1
20010037163 Allard Nov 2001 A1
20010048464 Barnett Dec 2001 A1
20010051881 Filler Dec 2001 A1
20010054071 Loeb Dec 2001 A1
20010055373 Yamashita Dec 2001 A1
20020015296 Howell et al. Feb 2002 A1
20020021791 Heilmann et al. Feb 2002 A1
20020027597 Sachau Mar 2002 A1
20020027652 Paromtchik et al. Mar 2002 A1
20020033880 Sul et al. Mar 2002 A1
20020038168 Kasuga et al. Mar 2002 A1
20020044201 Alexander et al. Apr 2002 A1
20020049517 Ruffner Apr 2002 A1
20020055917 Muraca May 2002 A1
20020057279 Jouppi May 2002 A1
20020058929 Green May 2002 A1
20020059587 Cofano et al. May 2002 A1
20020063726 Jouppi May 2002 A1
20020073429 Beane et al. Jun 2002 A1
20020082498 Wendt et al. Jun 2002 A1
20020085030 Ghani Jul 2002 A1
20020095238 Ahlin et al. Jul 2002 A1
20020095239 Wallach et al. Jul 2002 A1
20020098879 Rheey Jul 2002 A1
20020104094 Alexander et al. Aug 2002 A1
20020106998 Presley et al. Aug 2002 A1
20020109770 Terada Aug 2002 A1
20020109775 White et al. Aug 2002 A1
20020111988 Sato Aug 2002 A1
20020120362 Lathan et al. Aug 2002 A1
20020123941 Donahue et al. Sep 2002 A1
20020128985 Greenwald Sep 2002 A1
20020130950 James et al. Sep 2002 A1
20020133062 Arling et al. Sep 2002 A1
20020141595 Alexander Oct 2002 A1
20020143923 Alexander Oct 2002 A1
20020177925 Onishi et al. Nov 2002 A1
20020183894 Wang et al. Dec 2002 A1
20020184674 Xi et al. Dec 2002 A1
20020186243 Ellis et al. Dec 2002 A1
20030021107 Howell et al. Jan 2003 A1
20030030397 Simmons Feb 2003 A1
20030048481 Kobayashi et al. Mar 2003 A1
20030050733 Wang et al. Mar 2003 A1
20030050734 Lapham Mar 2003 A1
20030060808 Wilk Mar 2003 A1
20030063600 Noma et al. Apr 2003 A1
20030069752 Ledain et al. Apr 2003 A1
20030080901 Piotrowski May 2003 A1
20030100892 Morley et al. May 2003 A1
20030104806 Ruef et al. Jun 2003 A1
20030112823 Collins et al. Jun 2003 A1
20030114962 Niemeyer et al. Jun 2003 A1
20030120714 Wolff et al. Jun 2003 A1
20030126361 Slater et al. Jul 2003 A1
20030135097 Wiederhold et al. Jul 2003 A1
20030135203 Wang et al. Jul 2003 A1
20030144579 Buss Jul 2003 A1
20030144649 Ghodoussi et al. Jul 2003 A1
20030151658 Smith Aug 2003 A1
20030152145 Kawakita Aug 2003 A1
20030171710 Bassuk et al. Sep 2003 A1
20030174285 Trumbull Sep 2003 A1
20030180697 Kim et al. Sep 2003 A1
20030195662 Wang et al. Oct 2003 A1
20030199000 Valkirs et al. Oct 2003 A1
20030206242 Choi Nov 2003 A1
20030212472 Mckee Nov 2003 A1
20030216833 Mukai et al. Nov 2003 A1
20030216834 Allard Nov 2003 A1
20030220541 Salisbury et al. Nov 2003 A1
20030220715 Kneifel et al. Nov 2003 A1
20030231244 Bonilla et al. Dec 2003 A1
20030232649 Gizis et al. Dec 2003 A1
20030236590 Park et al. Dec 2003 A1
20040001197 Ko et al. Jan 2004 A1
20040001676 Colgan et al. Jan 2004 A1
20040008138 Hockley, Jr. et al. Jan 2004 A1
20040010344 Hiratsuka et al. Jan 2004 A1
20040012362 Tsurumi Jan 2004 A1
20040013295 Sabe et al. Jan 2004 A1
20040017475 Akers et al. Jan 2004 A1
20040019406 Wang et al. Jan 2004 A1
20040024490 Mclurkin et al. Feb 2004 A1
20040041904 Lapalme et al. Mar 2004 A1
20040065073 Nash Apr 2004 A1
20040068657 Alexander et al. Apr 2004 A1
20040078219 Kaylor et al. Apr 2004 A1
20040080610 James et al. Apr 2004 A1
20040088077 Jouppi et al. May 2004 A1
20040088078 Jouppi et al. May 2004 A1
20040093409 Thompson et al. May 2004 A1
20040095516 Rohlicek May 2004 A1
20040098167 Yi et al. May 2004 A1
20040102167 Shim et al. May 2004 A1
20040107254 Ludwig et al. Jun 2004 A1
20040107255 Ludwig et al. Jun 2004 A1
20040117065 Wang et al. Jun 2004 A1
20040117067 Jouppi Jun 2004 A1
20040123158 Roskind Jun 2004 A1
20040135879 Stacy et al. Jul 2004 A1
20040138547 Wang et al. Jul 2004 A1
20040143421 Wang et al. Jul 2004 A1
20040148638 Weisman et al. Jul 2004 A1
20040150725 Taguchi Aug 2004 A1
20040153211 Kamoto et al. Aug 2004 A1
20040157612 Kim, II Aug 2004 A1
20040162637 Wang et al. Aug 2004 A1
20040167666 Wang et al. Aug 2004 A1
20040167668 Wang et al. Aug 2004 A1
20040168148 Goncalves et al. Aug 2004 A1
20040170300 Jouppi Sep 2004 A1
20040172301 Mihai et al. Sep 2004 A1
20040172306 Wohl et al. Sep 2004 A1
20040174129 Wang et al. Sep 2004 A1
20040175684 Kaasa et al. Sep 2004 A1
20040179714 Jouppi Sep 2004 A1
20040186623 Dooley et al. Sep 2004 A1
20040189700 Mandavilli et al. Sep 2004 A1
20040201602 Mody et al. Oct 2004 A1
20040205664 Prendergast Oct 2004 A1
20040215490 Duchon et al. Oct 2004 A1
20040218099 Washington Nov 2004 A1
20040222638 Bednyak Nov 2004 A1
20040224676 Iseki Nov 2004 A1
20040230340 Fukuchi et al. Nov 2004 A1
20040240981 Dothan et al. Dec 2004 A1
20040241981 Doris et al. Dec 2004 A1
20040243712 Sakai et al. Dec 2004 A1
20040260790 Balloni et al. Dec 2004 A1
20050003330 Asgarinejad et al. Jan 2005 A1
20050004708 Goldenberg et al. Jan 2005 A1
20050007445 Foote et al. Jan 2005 A1
20050013149 Trossell Jan 2005 A1
20050021182 Wang et al. Jan 2005 A1
20050021183 Wang et al. Jan 2005 A1
20050021187 Wang et al. Jan 2005 A1
20050021309 Alexander et al. Jan 2005 A1
20050024485 Castles et al. Feb 2005 A1
20050027567 Taha Feb 2005 A1
20050027794 Decker Feb 2005 A1
20050028221 Liu et al. Feb 2005 A1
20050035862 Wildman et al. Feb 2005 A1
20050038416 Wang et al. Feb 2005 A1
20050038564 Burick Feb 2005 A1
20050049898 Hirakawa Mar 2005 A1
20050052527 Remy et al. Mar 2005 A1
20050060211 Xiao et al. Mar 2005 A1
20050065435 Rauch et al. Mar 2005 A1
20050065438 Miller Mar 2005 A1
20050065659 Tanaka et al. Mar 2005 A1
20050065813 Mishelevich et al. Mar 2005 A1
20050071046 Miyazaki et al. Mar 2005 A1
20050073575 Thacher et al. Apr 2005 A1
20050078816 Sekiguchi et al. Apr 2005 A1
20050083011 Yang et al. Apr 2005 A1
20050099493 Chew May 2005 A1
20050104964 Bovyrin et al. May 2005 A1
20050110867 Schulz May 2005 A1
20050122390 Wang et al. Jun 2005 A1
20050125083 Kiko Jun 2005 A1
20050125098 Wang et al. Jun 2005 A1
20050149364 Ombrellaro Jul 2005 A1
20050152447 Jouppi et al. Jul 2005 A1
20050152565 Jouppi et al. Jul 2005 A1
20050154265 Miro et al. Jul 2005 A1
20050165893 Feinberg et al. Jul 2005 A1
20050168568 Jouppi Aug 2005 A1
20050182322 Grispo Aug 2005 A1
20050192721 Jouppi Sep 2005 A1
20050204438 Wang et al. Sep 2005 A1
20050212478 Takenaka Sep 2005 A1
20050219356 Smith et al. Oct 2005 A1
20050225634 Brunetti et al. Oct 2005 A1
20050231156 Yan Oct 2005 A1
20050231586 Rodman et al. Oct 2005 A1
20050232647 Takenaka Oct 2005 A1
20050234592 Mcgee et al. Oct 2005 A1
20050264649 Chang et al. Dec 2005 A1
20050267826 Levy et al. Dec 2005 A1
20050283414 Fernandes et al. Dec 2005 A1
20050286759 Zitnick et al. Dec 2005 A1
20060007943 Fellman Jan 2006 A1
20060010028 Sorensen Jan 2006 A1
20060013263 Fellman Jan 2006 A1
20060013469 Wang et al. Jan 2006 A1
20060013488 Inoue Jan 2006 A1
20060014388 Lur et al. Jan 2006 A1
20060020694 Nag et al. Jan 2006 A1
20060029065 Fellman Feb 2006 A1
20060047365 Ghodoussi et al. Mar 2006 A1
20060048286 Donato Mar 2006 A1
20060052676 Wang et al. Mar 2006 A1
20060052684 Takahashi et al. Mar 2006 A1
20060056655 Wen et al. Mar 2006 A1
20060056837 Vapaakoski Mar 2006 A1
20060064212 Thorne Mar 2006 A1
20060066609 Iodice et al. Mar 2006 A1
20060071797 Rosenfeld et al. Apr 2006 A1
20060074525 Close et al. Apr 2006 A1
20060074719 Horner Apr 2006 A1
20060082642 Wang et al. Apr 2006 A1
20060087746 Lipow Apr 2006 A1
20060095158 Lee et al. May 2006 A1
20060095170 Yang et al. May 2006 A1
20060098573 Beer et al. May 2006 A1
20060103659 Karandikar et al. May 2006 A1
20060104279 Fellman et al. May 2006 A1
20060106493 Niemeyer et al. May 2006 A1
20060122482 Mariotti et al. Jun 2006 A1
20060125356 Meek et al. Jun 2006 A1
20060142983 Sorensen et al. Jun 2006 A1
20060149418 Anvari Jul 2006 A1
20060161136 Anderson Jul 2006 A1
20060161303 Wang et al. Jul 2006 A1
20060164546 Adachi Jul 2006 A1
20060171515 Hintermeister et al. Aug 2006 A1
20060173708 Vining et al. Aug 2006 A1
20060173712 Joubert Aug 2006 A1
20060178559 Kumar et al. Aug 2006 A1
20060178776 Feingold et al. Aug 2006 A1
20060178777 Park et al. Aug 2006 A1
20060189393 Edery Aug 2006 A1
20060195569 Barker Aug 2006 A1
20060224781 Tsao et al. Oct 2006 A1
20060238379 Kimchi et al. Oct 2006 A1
20060247045 Jeong et al. Nov 2006 A1
20060259193 Wang et al. Nov 2006 A1
20060268704 Ansari et al. Nov 2006 A1
20060271238 Choi et al. Nov 2006 A1
20060271400 Clements et al. Nov 2006 A1
20060293788 Pogodin Dec 2006 A1
20070021871 Wang et al. Jan 2007 A1
20070025711 Marcus Feb 2007 A1
20070046237 Lakshmanan et al. Mar 2007 A1
20070050937 Song et al. Mar 2007 A1
20070064092 Sandberg et al. Mar 2007 A1
20070078566 Wang et al. Apr 2007 A1
20070093279 Janik Apr 2007 A1
20070112700 Den et al. May 2007 A1
20070116152 Thesling May 2007 A1
20070117516 Saidi et al. May 2007 A1
20070120965 Sandberg et al. May 2007 A1
20070122783 Habashi May 2007 A1
20070133407 Choi et al. Jun 2007 A1
20070135967 Jung et al. Jun 2007 A1
20070142964 Abramson Jun 2007 A1
20070170886 Plishner Jul 2007 A1
20070176060 White et al. Aug 2007 A1
20070192910 Vu et al. Aug 2007 A1
20070197896 Moll et al. Aug 2007 A1
20070198128 Ziegler et al. Aug 2007 A1
20070198130 Wang et al. Aug 2007 A1
20070199108 Angle et al. Aug 2007 A1
20070216347 Kaneko et al. Sep 2007 A1
20070226949 Hahm et al. Oct 2007 A1
20070240203 Beck Oct 2007 A1
20070250212 Halloran et al. Oct 2007 A1
20070255706 Iketani et al. Nov 2007 A1
20070262884 Goncalves et al. Nov 2007 A1
20070273751 Sachau Nov 2007 A1
20070290040 Wurman et al. Dec 2007 A1
20070291109 Wang et al. Dec 2007 A1
20070291128 Wang et al. Dec 2007 A1
20080009969 Bruemmer et al. Jan 2008 A1
20080011904 Cepollina et al. Jan 2008 A1
20080027591 Lenser et al. Jan 2008 A1
20080033641 Medalia Feb 2008 A1
20080045804 Williams Feb 2008 A1
20080051985 D Andrea et al. Feb 2008 A1
20080065268 Wang et al. Mar 2008 A1
20080082211 Wang et al. Apr 2008 A1
20080086241 Phillips et al. Apr 2008 A1
20080091340 Milstein et al. Apr 2008 A1
20080126132 Warner et al. May 2008 A1
20080133052 Jones et al. Jun 2008 A1
20080161969 Lee et al. Jul 2008 A1
20080174570 Jobs et al. Jul 2008 A1
20080201016 Finlay Aug 2008 A1
20080201017 Wang et al. Aug 2008 A1
20080215987 Alexander et al. Sep 2008 A1
20080229531 Takida Sep 2008 A1
20080232763 Brady Sep 2008 A1
20080255703 Wang et al. Oct 2008 A1
20080263451 Portele et al. Oct 2008 A1
20080263628 Norman et al. Oct 2008 A1
20080267069 Thielman et al. Oct 2008 A1
20080269949 Norman et al. Oct 2008 A1
20080281467 Pinter Nov 2008 A1
20080306375 Sayler et al. Dec 2008 A1
20090030552 Nakadai et al. Jan 2009 A1
20090044334 Parsell et al. Feb 2009 A1
20090049640 Lee et al. Feb 2009 A1
20090055023 Walters et al. Feb 2009 A1
20090070135 Parida et al. Mar 2009 A1
20090086013 Thapa Apr 2009 A1
20090102919 Zamierowski et al. Apr 2009 A1
20090105882 Wang et al. Apr 2009 A1
20090106679 Anzures et al. Apr 2009 A1
20090122699 Alperovitch et al. May 2009 A1
20090125147 Wang et al. May 2009 A1
20090144425 Marr et al. Jun 2009 A1
20090164255 Menschik et al. Jun 2009 A1
20090164657 Li et al. Jun 2009 A1
20090171170 Li et al. Jul 2009 A1
20090177323 Ziegler et al. Jul 2009 A1
20090177641 Raghavan Jul 2009 A1
20090237317 Rofougaran Sep 2009 A1
20090240371 Wang et al. Sep 2009 A1
20090248200 Root Oct 2009 A1
20090259339 Wright Oct 2009 A1
20090284348 Pfeffer Nov 2009 A1
20100010672 Wang et al. Jan 2010 A1
20100010673 Wang et al. Jan 2010 A1
20100017046 Cheung et al. Jan 2010 A1
20100019715 Roe et al. Jan 2010 A1
20100026239 Li et al. Feb 2010 A1
20100030578 Siddique et al. Feb 2010 A1
20100051596 Diedrick et al. Mar 2010 A1
20100063848 Kremer et al. Mar 2010 A1
20100066804 Shoemake et al. Mar 2010 A1
20100070079 Mangaser et al. Mar 2010 A1
20100073490 Wang et al. Mar 2010 A1
20100076600 Cross et al. Mar 2010 A1
20100085874 Noy et al. Apr 2010 A1
20100088232 Gale Apr 2010 A1
20100115418 Wang et al. May 2010 A1
20100116566 Ohm et al. May 2010 A1
20100131103 Herzog et al. May 2010 A1
20100145479 Griffiths Jun 2010 A1
20100157825 Anderlind et al. Jun 2010 A1
20100171826 Hamilton et al. Jul 2010 A1
20100191375 Wright et al. Jul 2010 A1
20100228249 Mohr et al. Sep 2010 A1
20100251158 Geppert et al. Sep 2010 A1
20100268383 Wang et al. Oct 2010 A1
20100278086 Pochiraju et al. Nov 2010 A1
20100286905 Goncalves et al. Nov 2010 A1
20100301679 Murray et al. Dec 2010 A1
20100323783 Nonaka et al. Dec 2010 A1
20110022705 Yellamraju et al. Jan 2011 A1
20110050841 Wang et al. Mar 2011 A1
20110071675 Wells et al. Mar 2011 A1
20110071702 Wang et al. Mar 2011 A1
20110072114 Hoffert et al. Mar 2011 A1
20110117878 Barash et al. May 2011 A1
20110153198 Kokkas et al. Jun 2011 A1
20110172822 Ziegler et al. Jul 2011 A1
20110187875 Sanchez et al. Aug 2011 A1
20110190930 Hanrahan et al. Aug 2011 A1
20110193949 Nambakam et al. Aug 2011 A1
20110195701 Cook et al. Aug 2011 A1
20110213210 Temby et al. Sep 2011 A1
20110218674 Stuart et al. Sep 2011 A1
20110245973 Wang et al. Oct 2011 A1
20110280551 Sammon Nov 2011 A1
20110292193 Wang et al. Dec 2011 A1
20110301759 Wang et al. Dec 2011 A1
20110301971 Roesch et al. Dec 2011 A1
20110306400 Nguyen Dec 2011 A1
20120023506 Maeckel et al. Jan 2012 A1
20120036484 Zhang et al. Feb 2012 A1
20120059946 Wang Mar 2012 A1
20120072023 Ota Mar 2012 A1
20120072024 Wang et al. Mar 2012 A1
20120092157 Tran Apr 2012 A1
20120095352 Tran Apr 2012 A1
20120113856 Krishnaswamy May 2012 A1
20120191246 Roe et al. Jul 2012 A1
20120191464 Stuart et al. Jul 2012 A1
20120203731 Nelson et al. Aug 2012 A1
20120291809 Kuhe et al. Nov 2012 A1
20130002805 Andresen et al. Jan 2013 A1
20130250938 Anandakumar et al. Sep 2013 A1
20130321257 Moore et al. Dec 2013 A1
20140032244 Kolls et al. Jan 2014 A1
20140047022 Chan et al. Feb 2014 A1
20140085543 Hartley et al. Mar 2014 A1
20140135990 Stuart et al. May 2014 A1
20140139616 Pinter et al. May 2014 A1
20140155755 Pinter et al. Jun 2014 A1
20140250191 Altman et al. Sep 2014 A1
20150053689 Chhina Feb 2015 A1
20160154940 Ross et al. Jun 2016 A1
Foreign Referenced Citations (128)
Number Date Country
1216200 May 2000 AU
2289697 Nov 1998 CA
1404695 Mar 2003 CN
1554193 Dec 2004 CN
1554985 Dec 2004 CN
1561923 Jan 2005 CN
1743144 Mar 2006 CN
101049017 Oct 2007 CN
101106939 Jan 2008 CN
101151614 Mar 2008 CN
100407729 Jul 2008 CN
101390098 Mar 2009 CN
101507260 Aug 2009 CN
101730894 Jun 2010 CN
101866396 Oct 2010 CN
101978365 Feb 2011 CN
102203759 Sep 2011 CN
101106939 Nov 2011 CN
466492 Jan 1992 EP
488673 Jun 1992 EP
0981905 Jan 2002 EP
1262142 Dec 2002 EP
1304872 Apr 2003 EP
1536660 Jun 2005 EP
1573406 Sep 2005 EP
1594660 Nov 2005 EP
1763243 Mar 2007 EP
1791464 Jun 2007 EP
1800476 Jun 2007 EP
1819108 Aug 2007 EP
1856644 Nov 2007 EP
1536660 Apr 2008 EP
1928310 Jun 2008 EP
1232610 Jan 2009 EP
2027716 Feb 2009 EP
2145274 Jan 2010 EP
2214111 Aug 2010 EP
2263158 Dec 2010 EP
2300930 Mar 2011 EP
2342651 Jul 2011 EP
2431261 Apr 2007 GB
7194609 Aug 1995 JP
7213753 Aug 1995 JP
7248823 Sep 1995 JP
7257422 Oct 1995 JP
884328 Mar 1996 JP
8320727 Dec 1996 JP
9267276 Oct 1997 JP
1079097 Mar 1998 JP
10288689 Oct 1998 JP
11220706 Aug 1999 JP
2000-032319 Jan 2000 JP
2000-049800 Feb 2000 JP
2000-079587 Mar 2000 JP
2000-196876 Jul 2000 JP
2001-125641 May 2001 JP
2001-147718 May 2001 JP
2001-179663 Jul 2001 JP
2001-188124 Jul 2001 JP
2001-198865 Jul 2001 JP
2001-198868 Jul 2001 JP
2001-199356 Jul 2001 JP
2002-000574 Jan 2002 JP
2002-046088 Feb 2002 JP
2002-101333 Apr 2002 JP
2002-112970 Apr 2002 JP
2002-235423 Aug 2002 JP
2002-305743 Oct 2002 JP
2002-321180 Nov 2002 JP
2002-355779 Dec 2002 JP
2004-181229 Jul 2004 JP
2004-524824 Aug 2004 JP
2004-261941 Sep 2004 JP
2004-289379 Oct 2004 JP
2005-028066 Feb 2005 JP
2005-059170 Mar 2005 JP
2005-111083 Apr 2005 JP
2006-508806 Mar 2006 JP
2006-109094 Apr 2006 JP
2006-224294 Aug 2006 JP
2006-246438 Sep 2006 JP
2007-007040 Jan 2007 JP
2007-081646 Mar 2007 JP
2007-232208 Sep 2007 JP
2007-316966 Dec 2007 JP
2009-125133 Jun 2009 JP
2010-064154 Mar 2010 JP
2010-532109 Sep 2010 JP
2010-246954 Nov 2010 JP
20060037979 May 2006 KR
10-2009-0012542 Feb 2009 KR
20100019479 Feb 2010 KR
20100139037 Dec 2010 KR
9306690 Apr 1993 WO
97042761 Nov 1997 WO
1998051078 Nov 1998 WO
99067067 Dec 1999 WO
2000025516 May 2000 WO
2000033726 Jun 2000 WO
0131861 May 2001 WO
2003077745 Sep 2003 WO
2004008738 Jan 2004 WO
2004012018 Feb 2004 WO
2004075456 Sep 2004 WO
2006012797 Feb 2006 WO
2006044847 Apr 2006 WO
2006078611 Jul 2006 WO
2007041295 Apr 2007 WO
2007041038 Jun 2007 WO
2008100272 Aug 2008 WO
2008100272 Oct 2008 WO
2009117274 Sep 2009 WO
2009128997 Oct 2009 WO
2009145958 Dec 2009 WO
2010006205 Jan 2010 WO
2010006211 Jan 2010 WO
2010033666 Mar 2010 WO
2010047881 Apr 2010 WO
2010062798 Jun 2010 WO
2010065257 Jun 2010 WO
2010120407 Oct 2010 WO
2011028589 Mar 2011 WO
2011028589 Apr 2011 WO
2011097130 Aug 2011 WO
2011097132 Aug 2011 WO
2011109336 Sep 2011 WO
2011097132 Dec 2011 WO
2011149902 Dec 2011 WO
Non-Patent Literature Citations (202)
Entry
Paulos et al., “Social Tele-Embodiment: Understanding Presence”, Autonomous Robots, vol. 11, Issue 1, Kluwer Academic Publishers, Jul. 2001, pp. 87-95.
Paulos et al., “Ubiquitous Tele-Embodiment: Applications and Implications”, International Journal of Human Computer Studies, vol. 46, No. 6, Jun. 1997, pp. 861-877.
Paulos, “Video of PRoP 2 at Richmond Field Station”, www.prop.org Printout of Home Page of Website and two-page Transcript of the audio portion of said PRoP Video, May 2001.
International Preliminary Report on Patentability and Written Opinion received for PCT Patent Application No. PCT/US2005/037347, dated Apr. 17, 2006, 7 pages.
International Preliminary Report on Patentability and Written Opinion received for PCT Patent Application No. PCT/US2006/037076, dated Apr. 1, 2008, 6 pages.
International Search Report and Written Opinion received for PCT Application No. PCT/US2006/037076, dated May 11, 2007, 6 pages.
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US/2007/014099, dated Dec. 16, 2008, 5 pages.
International Search Report received for PCT Patent Application No. PCT/US2007/014099, dated Jul. 30, 2008, 1 page.
Picturetel Corporation, “PictureTel Live200 for Windows NT Product Guide”, 1997, 63 pages.
Pin et al., “A New Family of Omnidirectional and Holonomic Wheeled Platforms for Mobile Robots”, IEEE Transactions on Robotics and Automation, vol. 10, No. 4, Aug. 1994, pp. 480-489.
Piquepaille, Roland, “This Blog and its RSS Feed Are Moving”, Roland Piquepaille's Technology Trends, How new technologies are modifying our way of life, Oct. 31, 2004, 2 pages.
Radvision, “Making Sense of Bandwidth the NetsenseWay”, Network Congestion in Unmanaged Networks Bandwidth Estimation and Adaptation Techniques,White Paper, Radvision's Netsense Technology, 2010, 7 pages.
Reynolds et al., “Review of Robotic Telemedicine Utilization in Intensive Care Units (ICUs)”, 11th Annual ATA Symposium, Tampa, Florida, 2011, 1 page.
Roach, Adam, “Automatic Call Back Service in SIP”, Internet Engineering Task Force, Internet Draft, Category: Informational, Mar. 2000, 8 pages.
Rovetta et al., “A New Telerobotic Application: Remote Laparoscopic Surgery Using Satellites and optical fiber Networks for Data Exchange”, International Journal of Robotics Research, vol. 15, No. 3, Jun. 1, 1996, pp. 267-279.
Roy et al., “Towards Personal Service Robots for the Elderly”, Workshop on Interactive Robots and Entertainment (Wire 2000), Online available at <http://www.ri.cmu.edu/pb-files/pub2/roy-nicholas-2000-1/roy-nicholas-2000-1.pdf>, vol. 25, Apr. 30-May 1, 2000, 7 pages.
Sachs et al., “Virtual Visit: Improving Communication for Those Who Need it Most”, Studies in Health Technology and Informatics, vol. 94, Medicine Meets Virtual Reality 11, 2003, pp. 302-308.
Salemi et al., “MILO: Personal Robot Platform”, IEEE/RSJ International Conference on Intelligent Robots and Systems, Aug. 2005, pp. 4089-4094.
Sandt et al., “Perceptions for a Transport Robot in Public Environments”, Proceedings of the 1997 IEEE/RSJ International Conference on Intelligent Robots and Systems, vol. 1, Sep. 7-11, 1997, pp. 360-365.
Sawyer, Robert J., “Inventing the Future: 2000 Years of Discovery”, Available online at <http://www.sfwriter.com/pritf.htm>, Retrieved on May 25, 2008, Jan. 2, 2000, 2 pages.
Schaeffer et al., “Care-O-BotTM: The Concept of a System for Assisting Elderly or Disabled Persons in Home Environments”, Proceedings of the 24th Annual Conference of the IEEE Industrial Electronics Society, vol. 4, 1998, pp. 2476-2481.
Schraft et al., “Care-O-bot: the Concept of a System for Assisting Elderly or Disabled Persons in Home Enviornments”, IEEE Proceedings of the 24th Annual Conference of the Industrial Electronics Society, IECON '98, Aug. 31-Sep. 4, 1998, pp. 2476-2481.
Schultz et al., “Web Interfaces for Mobile Robots in Public Places”, IEEE Robotics and Automation Magazine, vol. 7 , No. 1, Mar. 2000, pp. 48-56.
Shimoga et al., “Touch and Force Reflection for Telepresence Surgery”, Proceedings of the 16th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Nov. 1994, pp. 1049-1050.
Siegwart et al., “Interacting Mobile Robots on the Web”, Proceedings of the 1999 IEEE International Conference on Robotics and Automation, May 1999, pp. 1-7.
Simmons et al., “Xavier: An Autonomous Mobile Robot on the Web”, IEEE Robotics and Automation Magazine, 1999, pp. 43-48.
Stephenson, Gary, “Dr. Robot Tested at Hopkins”, Available at <http://www.hopkinsmedicine.org/press/2003/august/030805.htm>, Aug. 5, 2003, 2 pages.
Stoianovici et al., “Robotic Tools for Minimally Invasive Urologic Surgery”, Complications of Urologic Laparoscopic Surgery: Recognition, Management and Prevention, Dec. 2002, 17 pages.
Suplee, Curt, “Mastering the Robot”, The Washington Post, Washington Post Staff Writer, Sep. 17, 2000, 5 pages.
Tahboub et al., “Dynamics Analysis and Control of a Holonomic Vehicle With Continuously Variable Transmission”, Transactions of the ASME , Journal of Dynamic Systems, Measurement and Control, vol. 124, Mar. 2002, pp. 118-126.
Telepresence Research, Inc., “The Telepresence Mobile Robot System”, Available at <http://www.telepresence.com/telepresence-research/TELEROBOT/>, Retrieved on Nov. 23, 2010, Feb. 20, 1995, 3 pages.
Tendick et al., “Human-Machine Interfaces for Minimally Invasive Surgery”, vol. 6, Proceedings of the 19th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Oct. 30-Nov. 2, 1997, pp. 2771-2776.
Theodosiou et al., “MuLVAT: A Video Annotation Tool Based on XML-Dictionaries and Shot Clustering”, Part II, 19th International Conference, Artificial Neural Networks—ICANN 2009, Sep. 14-17, 2009, pp. 913-922.
Thrun et al., “Probabilistic Algorithms and the Interactive Museum Tour-Guide Robot Minerva”, vol. 19, International Journal of Robotics Research, 2000, pp. 1-35.
Time, Lists, “Office Coworker Robot”, Best Inventions of 2001, Available at <http://content.time.com/time/specials/packages/article/0,28804,1936165_1936255_1936640,00.html>, Nov. 19, 2001, 2 pages.
Tipsuwan et al., “Gain Adaptation of Networked Mobile Robot to Compensate QoS Deterioration”, 28th Annual conference of the Industrial Electronics Society, vol. 4, Nov. 5-8, 2002, pp. 3146-3151.
Tsui et al., “Exploring Use Cases for Telepresence Robots”, 6th ACM/IEEE International Conference on Human-Robot Interaction (HRI), Mar. 2011, pp. 11-18.
Tyrrell et al., “Teleconsultation in Psychology: The Use of Videolinks for Interviewing and Assessing Elderly Patients”, Age and Ageing, vol. 30, No. 3, May 2001, pp. 191-195.
Tzafestas et al., “VR-Based Teleoperation of a Mobile Robotic Assistant: Progress Report”, Technical Report Demo 2000/13, Institute of Informatics and Telecommunications, National Center for Scientific Research “Demokritos”, Nov. 2000, pp. 1-23.
UMASS Lowell Robotics Lab, “Robotics Lab at UMASS Lowell”, Brochure, 2011, 2 pages.
Urquhart, Kim, “InTouch's Robotic Companion ‘Beams Up’ Healthcare Experts”, Medical Device Daily, vol. 7, No. 39, Feb. 27, 2003, pp. 1, 4.
Video Middleware Cookbook, “H.350 Directory Services for Multimedia”, 2 pages.
Weaver et al., “Monitoring and Controlling Using the Internet and Java”, Proceedings of the 25th Annual Conference of the IEEE Industrial Electronics Society, vol. 3, 1999, pp. 1152-1158.
Weiss et al., “Pebbles: A Personal Technology for Meeting Education, Social and Emotional Needs of Hospitalised Children”, Personal and Ubiquitous Computing, vol. 5, No. 3, Aug. 2001, pp. 157-168.
Weiss et al., “Telework and Video-Mediated Communication: Importance of Real-Time, Interactive Communication for Workers with Disabilities”, Available at <http://www.telbotics.com/research-3.htm>, Retrieved on Nov. 23, 2010, 3 pages.
West et al., “Design of Ball Wheel Mechanisms for Omnidirectional Vehicles with Full Mobility and Invariant Kinematics”, Journal of Mechanical Design , vol. 119, Jun. 1997, pp. 153-161.
Yamasaki et al., “Applying Personal Robots and Active Interface to Video Conference Systems”, 6th International Conference on Human Computer Interaction, vol. 20, Issue B, 1995, pp. 243-248.
Yamauchi, Brian, “PackBot: A Versatile Platform for Military Robotics”, Proceedings of SPIE for Military Robotics, 2004, pp. 228-237.
Yong et al., “Robot Task Execution with Telepresence Using Virtual Reality Technology”, 1998 International Conference on Mechatronic Technology, Nov. 30-Dec. 2, 1998, pp. 1-8.
Zambroski, James, “CMU, Pitt Developing ‘Nursebot’”, Available at <http://www.cs.cmu.edu/nursebot/web/press/tribunereview.html>, Retrieved on Jun. 26, 2012, Oct. 27, 2000, 3 pages.
Zamrazil, Kristie, “Telemedicine in Texas: Public Policy Concerns”, Focus Report, House Research Organization, Texas House of Representatives, No. 76-22, May 5, 2000, pp. 1-16.
Zipperer, Lorri, “Robotic Dispensing System”, ISMP Medication Safety Alert., vol. 4, No. 17, Aug. 25, 1999, 2 pages.
Screenshot Showing Google Date for Lemaire Telehealth Manual, screenshot retrieved on Dec. 18, 2014, 1 page.
Appeal from the U.S. District Court for the Central District of California in case No. 11-cv-9185, Judge Percy Anderson, Joint Appendix, vol. I of IV, Jun. 24, 2013, pp. A1-A6357.
Appeal from the U.S. District Court for the Central District of California in case No. 11-cv-9185, Judge Percy Anderson, Joint Appendix, vol. II of IV, Jun. 24, 2013, pp. A6849-A10634.
Appeal from the U.S. District Court for the Central District of California in case No. 11-cv-9185, Judge Percy Anderson, Joint Appendix, vol. III of IV, Jun. 24, 2013, pp. A10654-A15517.
Appeal from the U.S. District Court for the Central District of California in case No. 11-cv-9185, Judge Percy Anderson, Joint Appendix, vol. IV of IV, Jun. 24, 2013, pp. A15677-A18127.
Appeal from the U.S. District Court for the Central District of California in No. 11-CV-9185, Judge Percy Anderson, May 9, 2014, pp. 1-48.
Civil Minutes-General: Case No. CV 11-9185PA (AJWx), InTouch Tech., Inc. v. VGO Commons, Inc., Sep. 10, 2012, 7 pages.
Defendant VGO Communications, Inc.'s Invalidity Contentions Pursuant to the Feb. 27, 2012 Civil Minute Order, May 2, 2012, 143 pages.
Defendant-Counterclaimant VGO Communications, Inc.'s Supplemental Invalidity Contentions Pursuant to the Feb. 27, 2012 Civil Minute Order, May 14, 2012, 228 pages.
Google translation of: Innovations Report, From research project to television star: Care-O-bot in ZDF series, Online available at <http://www.innovations-report.de/specials/printa.php?id=5157>, Sep. 28, 2001, 2 pages.
Magne Charge, Smart Power for Electric Vehicles, Aug. 26, 1997, 2 pages.
More Online Robots: Robots that Manipulate, available online at <http://ford.ieor.berkeley.edu/ir/robots-a2.html>, Retrieved on Nov. 23, 2010, Aug. 2001, 2 pages.
MPEG File Format Summary, Downloaded from: <http://www.fileformat.info/format/mpeg/egff.htm>, Feb. 1, 2001, 8 pages.
Nomad Scout Language Reference Manual, Nomadic Technologies, Software Version 21, Part No. DOC00002, Jul. 12, 1999, 47 pages.
Nomad Scout User's Manual, Nomadic Technologies, Software Version 2. 7, Part No. DOC00004, Jul. 12, 1999, pp. 1-59.
Zorn, Benjamin G., “Ubiquitous Telepresence”, Department of Computer Science, University of Colorado, 1996, 13 pages.
Opening Brief for Plaintiff-Appellant InTouch Technologies, Inc., Appeal from the U.S. District Court for the Central District of California in Case No. 11-cv-9185, Judge Percy Anderson, Apr. 12, 2013, 187 pages.
PictureTel Adds New Features and Functionality to Its Award-Winning Live200 Desktop Videoconferencing System, PR Newswire Association, LLC, Gale, Cengage Learning, Jun. 13, 1997, 5 pages.
Reply Brief for Defendant-Appellee VGO Communications, Inc., Appeal from the U.S. District Court for the Central District of California, in Case No. 2:11-cv-9185, Judge Percy Anderson, May 28, 2013, 75 pages.
Reply Brief for Plaintiff-Appellant InTouch Technologies, Inc., Appeal from the U.S. District Court for the Central District of California in Case No. 11-cv-9185, Judge Percy Anderson, Jun. 14, 2013, 39 pages.
Robart I, II, III, Spawar, Systems Center Pacific, 1998, 8 pages.
Using your Infrared Cell Phone Camera, Online available at <http://www.catsdomain.com/xray/about.htm>, Courtesy of Internet Wayback Machine, Jan. 30, 2010, 4 pages.
U.S. Appl. No. 10/783,760, filed Feb. 20, 2004, 48 pages.
Office Action Received for Chinese Patent Application No. 200680044698.0, dated Nov. 4, 2010, 26 pages.
U.S. Appl. No. 60/449,762, filed Feb. 24, 2003, 28 pages.
ACM Digital Library Record, “Autonomous Robots”, Downloaded from <http://dl.acm.org/citation.cfm?id=591550ANDpicked=proxANDcfid=360891374ANDcftoken=35225929>, vol. 11, Issue 1, Jul. 2001, 2 pages.
Activemedia, Inc., “Saphira Software Manual”, Saphira Version 5.3, ActiveMedia, Inc., 1997, 105 pages.
Activmedia Robotics, “Pioneer 2/PeopleBot TM”, Operations Manual , Version 9, Oct. 2001, 78 pages.
Adams, Chris, “Simulation of Adaptive Behavior (SAB'02)”, Mobile Robotics Research Group, The Seventh International Conference, retrieved on Jan. 22, 2014, available at: http://www.dai.ed.ac.uk/groups/mrg/MRG.html, Aug. 4-11, 2002, 1 page.
Ando et al., “A Multimedia Self-service Terminal with Conferencing Functions”, Robot and Human Communication, RO-MAN'95, Tokyo, Proceedings of 4th IEEE International Workshop, Jul. 5-7, 1995, pp. 357-362.
Android Amusement Corp., “What Marketing Secret Renting Robots from Android Amusement Corp!”, (Advertisement), 1982, 1 page.
Apple Inc., “I Phone”, iPhone Series, XP002696350, Sep. 21, 2012, pp. 1-29.
Applebome, Peter, “Planning Domesticated Robots for Tomorrow's Household”, New York Times, Online available at <http://www.theoldrobots.com/images17/dc17.JPG>, Mar. 4, 1982, pp. 21 and 23.
Bar-Cohen et al., “Virtual Reality Robotic Telesurgery Simulations Using MEMICA Haptic System”, Proceedings of SPIE's 8th Annual International Symposium on Smart Structures and Materials, Mar. 5-8, 2001, pp. 1-7.
Barrett, Rick, “Video Conferencing Business Soars as Companies Cut Travel, Some Travel Cuts Are Permanent”, http://www.ivci.com/international_video_conferencing_news_videoconferencing_news_19.html, May 13, 2002, 2 pages.
Bartholomew, “Pharmacy Apothecary”, available online at <http://classes.bnf.fr/ema/grands/034.htm>, retrieved on Jul. 26, 2012, 2 pages.
Bauer et al., “Remote Telesurgical Mentoring: Feasibility and Efficacy”, IEEE, Proceedings of the 33rd Hawaii International Conference on System Sciences, 2000, pp. 1-9.
Bauer, Jeffrey C., “Service Robots in Health Care: The Evolution of Mechanical Solutions to Human Resource Problems”, Bon Secours Health System Inc., Technology Early Warning System(TEWS), Future of Service Robots in Health Care, Jun. 2003, pp. 1-10.
Bischoff, Rainer, “Design Concept and Realization of the Humanoid Service Robot HERMES”, Field and Service Robotics, Springer, 1998, pp. 485-492.
Blackwell, Gerry, “Video: A Wireless LAN Killer App?”, Availabel online at <http://www.wi-fiplanet.com/columns/article.php/1010261/Video-A-Wireless-LAN-Killer<, Retrieved on Nov. 22, 2010, Apr. 16, 2002, 4 pages.
Blaer et al., “TopBot: Automated Network Topology Detection With a Mobile Robot”, IEEE, Proceedings of the 2003 International Conference on Robotics 7 Automation, Taipei, Taiwan, Sep. 14-19, 2003, pp. 1582-1587.
Bradner, S., “The Internet Standards Process—Revision 3”, Network Working Group, Request for Comments: 2026, BCP: 9, Obsoletes: 1602, Category: Best Current Practice, Oct. 1996, pp. 1-36.
Brenner, Pablo, “A technical tutorial on the IEEE 802.11 protocol”, BreezeCOM Wireless Communications, 1997, pp. 1-24.
Breslow et al., “Effect of a Multiple-Site Intensive Care Unit Telemedicine Program on Clinical and Economic Outcome an Alternative Paradigm for Intensivist Staffing”, Critical Care Med, vol. 32, No. 1, Jan. 2004, pp. 31-38.
Brooks, Rodney, “A Robust Layered Control System for a Mobile Robot”, IEEE, Journal of Robotics and Automation, vol. 2, No. 1, Mar. 1986, pp. 14-23.
Brooks, Rodney Allen, “Remote Presence”, Abstracts from Flesh and Machines, How Robots Will Change Us, Feb. 2002, pp. 131-147.
Celi et al., “The eICU: It's Not Just Telemedicine”, Critical Care Medicine vol. 29, No. 8 (Supplement), Aug. 2001, pp. 183-189.
Cheetham et al., “Interface Development for a Child's Video Conferencing Robot”, Available online at <www.ryerson.ca/pebbles/publications/paper-iea200hfes-last.pdf>, 2000, 4 pages.
Christensen et al., “BeeSoft User's Guide and Reference”, Robots for the Real World™, Real World Interface, Inc ., Sep. 26, 1997, 203 pages.
Chu et al., “Detection of Target Mobile Signal Strength”, Technical Development, Motorola Inc, Jan. 1999, pp. 205-206.
Jouppi et al., “BiReality: Mutually-Immersive Telepresence”, Multimedia '04, Proceedings of the 12th Annual ACM International Conference on Multimedia, Oct. 10-16, 2004, pp. 860-867.
Jouppi et al., “First Steps Towards Mutually-Immersive Mobile Telepresence”, CSCW '02, Proceedings of the 2002 ACM conference on Computer Supported Cooperative Work, Nov. 16-20, 2002, pp. 354-363.
Kanehiro et al., “Virtual Humanoid Robot Platform to Develop Controllers of Real Humanoid Robots without Porting”, Intelligent Robots and Systems, Proceedings of 2001 IEEE/RSJ International Conference, vol. 2, 2001, pp. 1093-1099.
Kaplan et al., “An Internet Accessible Telepresence”, Multimedia Systems Journal, vol. 5, 1996, 7 pages.
Keller et al., “Raven Interface Project”, The National Aviary's Teleconferencing Carnegie Mellon University Robot, Interaction and Visual Interface Design, School of Design, Carnegie Mellon University, 2001, 8 pages.
Khatib, “Robots in Human Environments”, Proceedings of International Conference on Control, Automation, Robotics, and Vision ICRACV2000, 1999, 15 pages.
Knight et al., “Active Visual Alignment of a Mobile Stereo Camera Platform”, Robotics and Automation, Proceedings of ICRA '00 IEEE International Conference, vol. 4, Apr. 24-28, 2000, pp. 3203-3208.
Koenen, Rob, “MPEG-4: a Powerful Standard for Use in Web and Television Environments”, (KPN Research), available online at <http://www.w3.org/Architecture/1998/06/Workshop/paper26>, Jul. 1, 1998, 4 pages.
Kurlowicz et al., “The Mini Mental State Examination (MMSE)”, Try This: Best Practices in Nursing Care to Older Adults, A series from the Hartford Institute of Geriatric Nursing, Issue No. 3, Jan. 1999, 2 pages.
Kuzuoka, et al., “Can the GestureCam Be a Surrogate?”, Proceedings of the Fourth European Conference on Computer-Supported Cooperative Work, 1995, pp. 181-196.
Lane, Earl, “Automated Aides”, Available online at <http://www.cs.cum.edu/nursebot/web/press/nd4380.htm>, Retrieved on Nov. 23, 2010, Oct. 17, 2000, 4 pages.
Lee et al., “A Novel Method of Surgical Instruction: International Telementoring”, World Journal of Urology, vol. 16, No. 6, Dec. 1998, pp. 367-370.
Leifer et al., “VIPRR: A Virtually in Person Rehabilitation Robot”, Proceedings of 1997 International Conference on Rehabilitation Robotics, Apr. 14-15, 1997, 4 pages.
Lemaire, Edward, “Using Communication Technology to Enhance Rehabilitation Services: A Solution Oriented User Manual”, Institute for Rehabilitation Research and Development, Terry Fox Mobile Clinic, The Rehabilitation Centre, Ottawa, Ontario, Canada, Version 2.0, Online available at <http://www.irrd.ca/telehealth/distfile/distman_v2_1.pdf>, 1998-2001, 104 pages.
Library of Congress, “008—Fixed-Length Data Elements (NR)”, MARC 21 Format for Classification Data, downloaded from <http://www.loc.gov/marc/classification/cd008.html>, Jan. 2000, pp. 1-14.
Lim et al., “Control to Realize Human-Like Walking of a Biped Humanoid Robot”, Systems, Man, and Cybernetics, 2000, IEEE International Conference, vol. 5, 2000, pp. 3271-3276.
Linebarger et al., “Concurrency Control Mechanisms for Closely Coupled Collaboration in Multithreaded Virtual Environments”, Department of Computer Science and Engineering, Lehigh University, vol. 13, 2004, 40 pages.
Long, “Robot Navigation Technology”, Available Online at <http://www.atp.nist.gov/eao/sp950-1/helpmate.htm>, Retrieved on Nov. 23, 2010, Mar. 1999, 3 pages.
Luna, Nancy, “Robot a New Face on Geriatric Care”, ocregister.com, Aug. 6, 2003, 3 pages.
Mack, Michael J., “Minimally Invasive and Robotic Surgery”, The Journal of the American Medical Association, vol. 285, No. 5, 2001, pp. 568-572.
Mair, G. M., “Telepresence—The Technology and its Economic and Social Implications”, Technology and Society, 1997. ‘Technology and Society at a Time of Sweeping Change’, Proceedings of 1997 International Symposium, Jun. 20-21, 1997, pp. 118-124.
Martin, Anya, “Brighter Days Ahead”, Assisted Living Today, vol. 9, Nov./Dec. 2002, pp. 19-22.
McCardle et al., “The Challenge of Utilizing New Technology in Design Education”, Loughborough University, Idater 2000, pp. 122-127.
Meng et al., “E-Service Robot in Home Healthcare”, Proceedings of the 2000 IEEE/RSJ, International Conference on Intelligent Robots and Systems, 2000, pp. 832-837.
Metz, Cade, “HP Labs”, Available Online at <http://www.pcmag.com/article2/0,2817,1130820,00.asp>, Jul. 1, 2003, 4 pages.
Michaud, Anne, “Introducing “Nursebot””, Available Online at <http://www.cs.cmu.edu/nursebot/web/press/globe 301/index.html>, Retrieved on May 5, 2008, 2001, 4 pages.
Microsoft Corporation, Inc., “Microsoft NetMeeting 3 Features excerpt from Official Microsoft NetMeeting 3.0 Book”, Available at <http://technet.microsoft.com/en-us/library/cc723477.aspx>, Retrieved on Jun. 26, 2012, 6 pages.
Minsky, Marvin, “Telepresence”, OMNI Magazine, Jun. 1980, 6 pages.
Montemerlo, “Telepresence: Experiments in Next Generation Internet”, Available Online at <http://www.ri.cmu.edu/creative/archives.htm>, Retrieved on May 25, 2008, Oct. 20, 1998.
Murphy, “Introduction to A1 Robotics”, A Bradford Book, The MIT Press, Cambridge, Massachusetts, London, England, 2000, 487 pages.
Nakajima et al., “A Multimedia Teleteaching System using an Electronic Whiteboard for Two Way Communication of Motion Videos and Chalkboards”, Robot and Human Communication, Proceedings of 2nd IEEE International Workshop, 1993, pp. 436-441.
Nakazato et al., “Group-Based Interface for Content-Based Image Retrieval”, Proceedings of the Working Conference on Advanced Visual Interfaces, 2002, pp. 187-194.
Nakazato et al., “ImageGrouper: A Group-Oriented User Interface for Content-Based Image Retrieval and Digital Image Arrangement”, Journal of Visual Languages and Computing, vol. 14, No. 4, Aug. 2003, pp. 45-46.
Nersc, “Berkeley Lab's RAGE Telepresence Robot Captures RANDD100 Award”, Available at <https://www.nersc.gov/news-publications/news/nersc-center-news/2002/berkeley-lab-s-rage-telepresence-robot-captures-r-and-d100-award/>, Retrieved on Jan. 22, 2014, Jul. 2, 2002, 2 pages.
Nomadic Technologies Inc., “Nomad XR4000 Hardware Manual”, Release 1.0, Mar. 1999, 34 pages.
Noritsugu, et al., “Application of Rubber Artificial Muscle Manipulator as a Rehabilitation Robot”, Mechatronics, IEEE/ASME Transactions, vol. 2, No. 4, Dec. 1997, pp. 259-267.
North, Michael, “Telemedicine: Sample Script and Specifications for a Demonstration of Simple Medical Diagnosis and Treatment Using Live Two-Way Video on a Computer Network”, Greenstar Corporation, 1998, 5 pages.
Ogata et al., “Development of Emotional Communication Robot: WAMOEBA-2R—Experimental evaluation”, Proceedings of the 2000 IEEE/RSJ International Conference on Intelligent Robots and Systems, vol. 1, 2000, pp. 175-180.
Ogata et al., “Emotional Communication Robot: WAMOEBA-2R—Emotion Model and Evaluation Experiments”, Proceedings of the International Conference on Humanoid Robots, 2000, pp. 1-16.
Oh et al., “Autonomous Battery Recharging for Indoor Mobile Robots”, Proceedings of Australian Conference on Robotics and Automation, 2000, pp. 1-6.
Ojha, Anand K., “An application of Virtual Reality in Rehabilitation”, Proceedings of the 1994 IEEE Southeastcon 94. Creative Technology Transfer—A Global Affair, Apr. 1994, pp. 4-6.
Osborn, Jim, “Quality of Life Technology Center”, QoLT Research Overview:A National Science Foundation Engineering Research Center, Carnegie Mellon University of Pittsburgh, 2 pages.
Panusopone et al., “Performance Comparison of MPEG-4 and H.263+ for Streaming Video Applications”, Circuits Systems Signal Processing, vol. 20, No. 3, 2001, pp. 293-309.
Paulos et al., “A World Wide Web Telerobotic Remote Environment Browser”, Available at <http://www.w3.org/Conferences/WWW4/Papers/326/>, Retrieved on Nov. 23, 2010, 1995, 15 pages.
Paulos et al., “Designing Personal Tele-Embodiment”, Proceedings of IEEE International Conference on Robotics and Automation, vol. 4, May 16-20, 1998, pp. 3173-3178.
Paulos, Eric J., “Personal Tele-Embodiment”, Dissertation, Doctor of Philosophy in Computer Science in the Graduate Division of the University of California at Berkeley, 2001, 282 pages.
Paulos, Eric John, “Personal Tele-Embodiment”, OskiCat Catalog Record, UCB Library Catalog, 2001, 3 pages.
Paulos, Eric John, “Personal Tele-Embodiment”, Introductory and cover pages from 2001 Dissertation including Contents table, together with e-mails relating thereto from UC Berkeley Libraries, as shelved at UC Berkeley Engineering Library (Northern Regional library Facility), May 8, 2002, 25 pages (including 4 pages of e-mails).
Paulos et al., “Personal Tele-Embodiment”, Chapter 9 in Goldberg et al., ed. “Beyond webcams”, MIT Press, Jan. 4, 2002, pp. 155-167.
Paulos et al., “PRoP: Personal Roving Presence”, ACM:CHI Proceedings of CHI '98, 1998, 8 pages.
Cleary et al., “State of the Art in Surgical Robotics: Clinical Applications and Technology Challenges”, Feb. 24, 2002, pp. 1-26.
CMU Course 16×62, “Robot user's manual”, (describing the Nomad Scout), Carnegie Mellon University, Feb. 1, 2001, 11 pages.
CNN, “Floating ‘Droids’ to Roam Space Corridors of the Future”, Available online at <http://edition.cnn.com/2000/TECH/space/01/12/psa/>, Retrieved on Nov. 11, 2010, Jan. 12, 2000, 3 pages.
cnn.com, “Paging Dr.Robot: Machine Helps Doctors with Patients”, Sep. 30, 2003, 3 pages.
Crowley, Susan L., “Hello to Our Future”, AARP Bulletin, Jan. 2000, 12 pages.
Dalton, Barnaby, “Techniques for Web Telerobotics”, PhD Thesis, University of Western Australia, 2001, 243 pages.
Dario et al., “A Robot Workstation for Diagnosis and Physical Therapy”, IEEE Catalog No. 88TH0234-5, 1989, pp. 67-72.
Davies, Brian, “Robotics in Minimally Invasive Surgery”, Mechatronics in Medicine Lab, Dept Mechanical Engineering, Imperial College, London SW7 2BX, 1995, pp. 1-2.
Davis, Erik, “Telefriend, Meet iRobot, The Smartest Webcam on Wheels”, Wired Magazine, Issue 8.09, Available at <http://www.wired.com/wired/archive/8.09/irobot.html?pg=1ANDtopic=ANDtopic-set=>, Sep. 2000, 3 pages.
Dean et al., “1992 AAAI Robot Exhibition and Competition”, Articles, AI Magazine, vol. 14, No. 1, 1993, 15 pages.
Digiorgio, James, “Is Your Emergency Department of the Leading Edge?”, Chicago Hospital News, vol. 2, No. 12, 2005, 3 pages.
Dudenhoeffer et al., “Command and Control Architectures for Autonomous Micro-Robotic Forces”, FY00 Project Report, Idaho National Engineering and Environmental Laboratory Human Systems Engineering and Sciences Department, Idaho Falls, Apr. 2001, 43 pages.
Elhajj et al., “Real-Time Haptic Feedback in Internet-Based Telerobotic Operation”, IEEE International Conference on Electro/Information Technology, Available online at <http://www.egr.msu.edu/ralab-web/cgi-bin/internet-teleoperation.php>, Jun. 2000, 10 pages.
Elhajj et al., “Supermedia in Internet-Based Telerobotic Operations”, Management of Multimedia on the Internet Lecture Notes in Computer Science, vol. 2216, Springer-Verlag Berlin Heidelberg, Oct. 29-Nov. 1, 2001, pp. 359-372.
Elhajj et al., “Synchronization and Control of Supermedia Transmission Via the Internet”, Proceedings of 2001 International Symposium on Intelligent Multimedia Video and Speech Processing, May 2-4, 2001, pp. 320-323.
Ellison et al., “Telerounding and Patient Satisfaction Following Surgery”, 2004, pp. 523-530.
Evans et al., “the Trackless Robotic Courier”, PYXIS HelpMate, 2007, 3 pages.
Fels et al., “Developing a Video-Mediated Communication System for Hospitalized Children”, Telemedicine Journal, vol. 5, No. 2, 1999, 30 pages.
Fetterman et al., “Videoconferencing Over the Internet”, 2001, 8 pages.
Fiorini et al., “Health Care Robotics: A Progress Report”, IEEE International Conference on Robotics and Automation, Apr. 20-25, 1997, pp. 1271-1276.
Fong, Terrence, “Collaborative Control: A Robot-Centric Model for Vehicle Teleoperation”, Doctoral Dissertation, Technical Report CMU-RI-TR-01-34, Robotics Institute, Carnegie Mellon University, Nov. 2001, 197 pages.
Fulbright et al., “SWAMI: An Autonomous Mobile Robot for Inspection of Nuclear Waste of Storage Facilities”, Autonomous Robots, vol. 2, 1995, pp. 225-235.
Gaidioz et al., “Synchronizing Network Probes to Avoid Measurement Intrusiveness with the Network Weather Service”, Proceedings of the Ninth Intemational Symposium on High-Performance Distributed Computing, 2000, pp. 147-154.
Garner et al., “The Application of Telepresence in Medicine”, BT Technology Journal, vol. 15, No. 4, Oct. 1, 1997, pp. 181-187.
Ghiasi et al., “A Generic Web-based Teleoperations Architecture: Details and Experience”, Proceedings of SPIE, Telemanipulator and Telepresence Technologies VI, vol. 3840, No. 234, Sep. 19, 1999, 14 pages.
Goldberg et al., “Collaborative Teleoperation via the Internet”, IEEE International Conference on Robotics and Automation (ICRA), vol. 2, 2000, pp. 2019-2024.
Goldberg et al., “Desktop Teleoperation via the World Wide Web”, Robotics and Automation, Proceedings of the 1995 IEEE International Conference, vol. 1, May 21-27, 1995, pp. 654-659.
Goldenberg et al., “Telemedicine in Otolaryngology”, American Journal of Otolaryngology, vol. 23, No. 1, 2002, pp. 35-43.
Goldman, Lea, “Machine Dreams”, Available Online at <http://www.forbes.com/global/2002/0527/043.html>, retrieved on Nov. 23, 2010, May 27, 2002, 5 pages.
Gostai, “Gostai Jazz: Robotic Telepresence”, Available online at <http://www.robotshop.com/media/files/pdf/gostai-jazz-information-sheet.pdf>, 4 pages.
Gump, Michael D., “Robot Technology Improves VA Pharmacies”, U.S. Medicine Informational Central, Jul. 2001, 3 pages.
Hameed et al., “A Review of Telemedicine”, Journal of Telemedicine and Telecare, vol. 5, Supplement 1, 1999, pp. 103-106.
Han et al., “Construction of an Omnidirectional Mobile Robot Platform Based on Active Dual-Wheel Caster Mechanisms and Development of a Control Simulator”, Kluwer Acedemic Publishers, vol. 29, Nov. 2000, pp. 257-275.
Handley et al., “RFC 2327—SDP: Session Description Protocol”, Available Online at <http://www.faqs.org/rfcs/rfc2327.html>, Retrieved on Nov. 23, 2010, Apr. 1998, 22 pages.
Hanebeck et al., “ROMAN: A Mobile Robotic Assistant for Indoor Service Applications”, Intelligent Robots and Systems, IROS '97, International Conference on Proceedings of the 1997 IEEE/RSJ, vol. 2, Sep. 7-11, 1997, pp. 518-525.
Harmo et al., “Moving Eye—Interactive Telepresence Over Internet With a Ball Shaped Mobile Robot”, Available Online at <http://automation.tkk.fi/files/tervetaas/MovingEye4.pdf>, 2000, 6 pages.
Haule et al., “Control Scheme for Delayed Teleoperation Tasks”, Communications, Computers, and Signal Processing, Proceedings of IEEE Pacific Rim Conference, May 17-19, 1995, pp. 157-160.
Hees, William P., “Communications Design for a Remote Presence Robot”, CSCI E-131b, Final Project, Jan. 14, 2002, 12 pages.
Herias et al., “Flexible Virtual and Remote Laboratory for Teaching Robotics”, FORMATEX 2006, Proc. Advance in Control Education Madrid, Spain, Jun. 2006, pp. 1959-1963.
Holmberg, “Development of a Holonomic Mobile Robot for Mobile Manipulation Tasks”, The Robotics Laboratory, Computer Science Department, Stanford University, Stanford, California, USA, vol. 19, No. 11, Nov. 2000, pp. 1066-1074.
Ishiguro et al., “Integrating a Perceptual Information Infrastructure with Robotic Avatars: A Framework for Tele-Existence”, Intelligent Robots and Systems, IROS '99, Proceedings of 1999 IEEE/RSJ International Conference, vol. 2, 1999, pp. 1032-1038.
Ishihara et al., “Intelligent Microrobot DDS (Drug Delivery System) Measured and Controlled by Ultrasonics”, Intelligent Robots and Systems '91, ‘Intelligence for Mechanical Systems, International Workshop on Proceedings of IROS '91 IEEE/RSJ, vol. 2, Nov. 3-5, 1991, pp. 1145-1150.
ITU, “Call Completion Supplementary Services for H.323”, ITU-T, Telecommunication Standardization Sector of ITU, H.450.9, Series H: Audiovisual and Multimedia Systems, Nov. 2000, 63 pages.
ITU, “Call Intrusion Supplementary Service for H.323”, ITU-T, Telecommunication Standardization Sector of ITU, H.450.11, Series H: Audiovisual and Multimedia Systems, Mar. 2001, 59 pages.
ITU, “Packet-Based Multimedia Communications Systems”, ITU-T, Telecommunication Standardization Sector of ITU, H.323, Series H: Audiovisual and Multimedia Systems, Feb. 1998, 128 pages.
ITU, “Transmission of Non-Telephone Signals: A Far End Camera Control Protocol for VideoConferences Using H.224”, ITU-T, Telecommunication Standardization Sector of ITU, H.281, Nov. 1994, 12 pages.
Ivanova, Natali, “Master's thesis: Internet Based Interface for Control of a Mobile Robot”, Department of Numerical Analysis and Computer Science, 2003, 59 pages.
Jacobs et al., “Applying Telemedicine to Outpatient Physical Therapy”, AMIA, Annual Symposium Proceedings, 2002, 1 page.
Jenkins et al., “Telehealth Advancing Nursing Practice”, Nursing Outlook, vol. 49, No. 2, Mar. 2001, pp. 100-105.
Johanson, Mathias, “Supporting Video-Mediated Communication Over the Internet”, Department of Computer Engineering, Chalmers University of Technology, Gothenburg, Sweden, 2003, 222 pages.
Related Publications (1)
Number Date Country
20160078193 A1 Mar 2016 US
Continuations (2)
Number Date Country
Parent 14528207 Oct 2014 US
Child 14949318 US
Parent 13558059 Jul 2012 US
Child 14528207 US
Continuation in Parts (1)
Number Date Country
Parent 13444106 Apr 2012 US
Child 13558059 US